Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	TFEB EBF3 ESR2 GLIS3 IRF1 POU2F2 ISL1 MEF2A PITX1 PITX2 PBX1 MGA NFAT5 ZNF292	1.57e-06	560	106	14	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	TFEB EBF3 ESR2 GLIS3 IRF1 POU2F2 ISL1 MEF2A PITX1 PITX2 PBX1 MGA NFAT5 ZNF292	1.78e-06	566	106	14	GO:0001216
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SOX6 NCOA2 TFEB HIVEP1 SALL3 EBF3 ESR2 GLIS3 GATA6 IRF1 POU2F2 ISL1 RFX7 MEF2A PITX1 PITX2 ZFHX2 KLF17 PBX1 MGA NFAT5	1.99e-06	1244	106	21	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SOX6 NCOA2 TFEB HIVEP1 SALL3 EBF3 ESR2 GLIS3 GATA6 IRF1 POU2F2 ISL1 RFX7 MEF2A PITX1 PITX2 ZFHX2 KLF17 PBX1 MGA NFAT5	2.80e-06	1271	106	21	GO:0000987
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SOX6 NCOA2 TFEB HIVEP1 SALL3 EBF3 ESR2 GLIS3 GATA6 IRF1 POU2F2 ISL1 RFX7 MEF2A PITX1 PITX2 ZFHX2 NCOA1 KLF17 PBX1 MGA NFAT5	6.83e-06	1459	106	22	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	SOX6 TFEB HIVEP1 SALL3 EBF3 ESR2 GLIS3 GATA6 IRF1 POU2F2 ISL1 RFX7 MEF2A PITX1 PITX2 ZFHX2 KLF17 PBX1 MGA NFAT5 ZNF292	1.42e-05	1412	106	21	GO:0000981
GeneOntologyMolecularFunction	co-SMAD binding	USP9X USP9Y TRIM33	3.09e-05	12	106	3	GO:0070410
GeneOntologyMolecularFunction	chromatin binding	NCOA2 NCOA6 ESR2 GATA6 ISL1 MEF2A GATAD2B WAC TRIM33 PHC3 PITX2 NCOA1 MLLT6 NFAT5	3.62e-05	739	106	14	GO:0003682
GeneOntologyMolecularFunction	SMAD binding	USP9X USP9Y MEF2A TRIM33 MYOCD	9.49e-05	86	106	5	GO:0046332
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA2 NCOA6 ISL1 NCOA1	1.80e-04	53	106	4	GO:0030331
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOA2 NCOA6 NCOA1	2.38e-04	23	106	3	GO:0046965
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	NCOA2 NCOA6 GATA6 CRTC1 ISL1 MEF2A PITX1 PITX2 NCOA1 MYOCD PBX1	2.67e-04	582	106	11	GO:0140297
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	NCOA2 NCOA6 GATA6 ISL1 MEF2A PITX1 PITX2 NCOA1 MYOCD	3.82e-04	417	106	9	GO:0061629
GeneOntologyMolecularFunction	transcription factor binding	NCOA2 NCOA6 GATA6 CRTC1 ISL1 MEF2A PITX1 PITX2 NCOA1 MYOCD PBX1 NFAT5	6.50e-04	753	106	12	GO:0008134
GeneOntologyMolecularFunction	RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding	NCOA2 HIVEP1	2.10e-03	13	106	2	GO:0001162
GeneOntologyMolecularFunction	axon guidance receptor activity	ROBO1 PALLD	2.10e-03	13	106	2	GO:0008046
GeneOntologyMolecularFunction	zinc ion binding	HIVEP1 ESR2 GATA6 MYRIP GATAD2B MAP3K1 ZCCHC14 TRIM33 PHC3 SEC24B ZFAND6 ZFHX2	2.71e-03	891	106	12	GO:0008270
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	NCOA2 NCOA6 NCOA1	3.12e-03	55	106	3	GO:0042974
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	CDK8 SOX6 NCOA2 TFEB NCOA6 HIVEP1 SUPT20H EBF3 BCLAF1 ESR2 GLIS3 GATA6 IRF1 POU2F2 CRTC1 ISL1 RFX7 MEF2A MAP3K1 ABLIM1 PITX1 PITX2 NCOA1 MLLT6 MYOCD MAML2 PBX1 MGA NFAT5 ZNF292	8.20e-12	1390	106	30	GO:0045944
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	SOX6 NCOA2 HIVEP1 BCLAF1 USP9X ESR2 GLIS3 GATA6 IRF1 ISL1 MEF2A GATAD2B TRIM33 PHC3 ZNF469 PITX1 PITX2 KLF17 MYOCD MAPK10	2.61e-05	1399	106	20	GO:0045892
GeneOntologyBiologicalProcess	regulation of microtubule polymerization	MAP1B HAUS5 TOGARAM1 PDE4DIP NAV3	2.82e-05	69	106	5	GO:0031113
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	SOX6 NCOA2 HIVEP1 BCLAF1 USP9X ESR2 GLIS3 GATA6 IRF1 ISL1 MEF2A GATAD2B TRIM33 PHC3 ZNF469 PITX1 PITX2 KLF17 MYOCD MAPK10	3.01e-05	1413	106	20	GO:1902679
GeneOntologyBiologicalProcess	brain development	SOX6 NCOA6 XRN2 SALL3 USP9X ESR2 ISL1 SCYL2 SEC24B PITX1 PITX2 NAV2 NCOA1 ROBO1 PBX1	3.29e-05	859	106	15	GO:0007420
GeneOntologyBiologicalProcess	positive regulation of microtubule polymerization	MAP1B TOGARAM1 PDE4DIP NAV3	3.82e-05	37	106	4	GO:0031116
GeneOntologyBiologicalProcess	positive regulation of microtubule polymerization or depolymerization	MAP1B TOGARAM1 PDE4DIP NAV3	6.35e-05	42	106	4	GO:0031112
GeneOntologyBiologicalProcess	head development	SOX6 NCOA6 XRN2 SALL3 USP9X ESR2 ISL1 SCYL2 SEC24B PITX1 PITX2 NAV2 NCOA1 ROBO1 PBX1	7.07e-05	919	106	15	GO:0060322
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	SOX6 NCOA2 HIVEP1 USP9X ESR2 GLIS3 GATA6 ISL1 MEF2A GATAD2B TRIM33 ZNF469 PITX2 KLF17 MYOCD MAPK10	9.23e-05	1053	106	16	GO:0000122
GeneOntologyBiologicalProcess	ventricular cardiac muscle cell differentiation	MEF2A PITX2 MYOCD	1.20e-04	19	106	3	GO:0055012
GeneOntologyBiologicalProcess	outflow tract morphogenesis	GATA6 ISL1 SEC24B PITX2 ROBO1	1.24e-04	94	106	5	GO:0003151
GeneOntologyBiologicalProcess	positive regulation of female receptivity	NCOA2 NCOA1	1.56e-04	4	106	2	GO:0045925
GeneOntologyBiologicalProcess	cellular response to Thyroglobulin triiodothyronine	NCOA2 NCOA1	1.56e-04	4	106	2	GO:1904017
GeneOntologyBiologicalProcess	positive regulation of protein polymerization	MAP1B TOGARAM1 MAP3K1 PDE4DIP NAV3	1.83e-04	102	106	5	GO:0032273
GeneOntologyBiologicalProcess	endocrine system development	RAP1GAP GATA6 ISL1 PITX1 PITX2 PBX1	1.85e-04	161	106	6	GO:0035270
GeneOntologyBiologicalProcess	regulation of microtubule polymerization or depolymerization	MAP1B HAUS5 TOGARAM1 PDE4DIP NAV3	2.39e-04	108	106	5	GO:0031110
GeneOntologyBiologicalProcess	atrial cardiac muscle tissue development	GATA6 ISL1 PITX2	2.79e-04	25	106	3	GO:0003228
GeneOntologyBiologicalProcess	positive regulation of axonogenesis	MAP1B TRAK1 ROBO1 MACF1 GOLGA4	3.07e-04	114	106	5	GO:0050772
GeneOntologyBiologicalProcess	cardiac muscle cell differentiation	SOX6 GATA6 ISL1 MEF2A PITX2 MYOCD	3.08e-04	177	106	6	GO:0055007
GeneOntologyBiologicalProcess	microtubule polymerization	MAP1B HAUS5 TOGARAM1 PDE4DIP NAV3	3.46e-04	117	106	5	GO:0046785
GeneOntologyBiologicalProcess	cell morphogenesis	SOX6 MAP1B USP9X FRYL ISL1 MAP7 MEF2A MAP3K1 TRAK1 ABLIM1 NEO1 SEC24B ROBO1 MACF1 PALLD GOLGA4	3.84e-04	1194	106	16	GO:0000902
GeneOntologyBiologicalProcess	response to Thyroglobulin triiodothyronine	NCOA2 NCOA1	3.87e-04	6	106	2	GO:1904016
GeneOntologyBiologicalProcess	outflow tract septum morphogenesis	GATA6 ISL1 ROBO1	3.94e-04	28	106	3	GO:0003148
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	MAP1B USP9X ISL1 MEF2A TRAK1 ABLIM1 NEO1 SEC24B ROBO1 MACF1 PALLD GOLGA4	4.61e-04	748	106	12	GO:0048667
GeneOntologyCellularComponent	transcription regulator complex	SOX6 NCOA2 TFEB NCOA6 GATA6 ISL1 MEF2A GATAD2B PITX1 PITX2 NCOA1 MYOCD PBX1 MGA NFAT5	2.93e-07	596	105	15	GO:0005667
GeneOntologyCellularComponent	chromatin	SOX6 NCOA2 TFEB SUPT20H EBF3 ESR2 GATA6 IRF1 POU2F2 ISL1 RFX7 MEF2A GATAD2B TRIM33 PITX1 PITX2 ZFHX2 NCOA1 KLF17 MYOCD PBX1 MGA NFAT5	9.36e-07	1480	105	23	GO:0000785
HumanPheno	Thin vermilion border	EBF3 USP9X GLIS3 GATA6 RFX7 GATAD2B WAC SCYL2 UBAP2L PITX2 NPAP1 PBX1 ZNF292	7.58e-06	433	38	13	HP:0000233
HumanPheno	Thin upper lip vermilion	EBF3 USP9X GLIS3 RFX7 GATAD2B WAC UBAP2L PITX2 NPAP1 PBX1 ZNF292	2.27e-05	339	38	11	HP:0000219
HumanPheno	Thin lips	EBF3 USP9X GLIS3 RFX7 GATAD2B WAC UBAP2L PITX2 NPAP1 PBX1 ZNF292	2.27e-05	339	38	11	HP:0000213
HumanPheno	Abnormality of the metopic suture	CDK8 MAP1B EBF3 TOGARAM1 UBAP2L ZNF292	6.89e-05	97	38	6	HP:0005556
HumanPheno	Abnormality of upper lip vermillion	MAP1B EBF3 USP9X GLIS3 RFX7 GATAD2B WAC UBAP2L PITX2 NPAP1 PBX1 ZNF292	8.46e-05	464	38	12	HP:0011339
MousePheno	lethality during fetal growth through weaning, complete penetrance	SOX6 NCOA6 SALL3 MAP1B EBF3 PODXL BCLAF1 BAG3 GLIS3 POU2F2 ISL1 RB1CC1 GATAD2B LIG1 NEO1 SEC24B PITX1 PITX2 ROBO1 MYOCD PBX1 NFAT5 PALLD	1.55e-06	1269	86	23	MP:0011111
Domain	SEA	MUC16 MUC12 TMPRSS11F MUC17	6.38e-06	22	105	4	PF01390
Domain	SEA	MUC16 MUC12 TMPRSS11F MUC17	7.69e-06	23	105	4	PS50024
Domain	SEA_dom	MUC16 MUC12 TMPRSS11F MUC17	7.69e-06	23	105	4	IPR000082
Domain	SEA	MUC16 TMPRSS11F MUC17	6.01e-05	14	105	3	SM00200
Domain	-	MUC16 TMPRSS11F MUC17	7.48e-05	15	105	3	3.30.70.960
Domain	DUF1518	NCOA2 NCOA1	9.36e-05	3	105	2	PF07469
Domain	DUF1518	NCOA2 NCOA1	9.36e-05	3	105	2	IPR010011
Domain	Nuc_rcpt_coact_Ncoa-typ	NCOA2 NCOA1	9.36e-05	3	105	2	IPR014920
Domain	SRC-1	NCOA2 NCOA1	9.36e-05	3	105	2	IPR014935
Domain	Homeobox_Pitx/unc30	PITX1 PITX2	9.36e-05	3	105	2	IPR016233
Domain	Src1_rcpt_coact	NCOA2 NCOA1	9.36e-05	3	105	2	IPR008955
Domain	Nuclear_rcpt_coactivator	NCOA2 NCOA1	9.36e-05	3	105	2	IPR017426
Domain	DUF1518	NCOA2 NCOA1	9.36e-05	3	105	2	SM01151
Domain	SRC-1	NCOA2 NCOA1	9.36e-05	3	105	2	PF08832
Domain	-	NCOA2 NCOA1	9.36e-05	3	105	2	4.10.630.10
Domain	Nuc_rec_co-act	NCOA2 NCOA1	9.36e-05	3	105	2	PF08815
Domain	Nuc_rcpt_coact	NCOA2 NCOA1	4.63e-04	6	105	2	IPR009110
Domain	CH	NAV3 NAV2 MACF1 MICAL3	4.91e-04	65	105	4	SM00033
Domain	HLH	NCOA2 TFEB EBF3 NCOA1 MGA	4.99e-04	116	105	5	SM00353
Domain	Homeobox_CS	POU2F2 ISL1 PITX1 PITX2 ZFHX2 PBX1	6.40e-04	186	105	6	IPR017970
Domain	CH	NAV3 NAV2 MACF1 MICAL3	6.50e-04	70	105	4	PF00307
Domain	-	NAV3 NAV2 MACF1 MICAL3	6.86e-04	71	105	4	1.10.418.10
Domain	CH	NAV3 NAV2 MACF1 MICAL3	7.62e-04	73	105	4	PS50021
Domain	CH-domain	NAV3 NAV2 MACF1 MICAL3	8.44e-04	75	105	4	IPR001715
Domain	Homeobox	POU2F2 ISL1 PITX1 PITX2 ZFHX2 PBX1	2.08e-03	234	105	6	PF00046
Domain	HOMEOBOX_1	POU2F2 ISL1 PITX1 PITX2 ZFHX2 PBX1	2.17e-03	236	105	6	PS00027
Domain	HOX	POU2F2 ISL1 PITX1 PITX2 ZFHX2 PBX1	2.22e-03	237	105	6	SM00389
Domain	HOMEOBOX_2	POU2F2 ISL1 PITX1 PITX2 ZFHX2 PBX1	2.31e-03	239	105	6	PS50071
Domain	Homeobox_dom	POU2F2 ISL1 PITX1 PITX2 ZFHX2 PBX1	2.31e-03	239	105	6	IPR001356
Domain	Znf_GATA	GATA6 GATAD2B	3.13e-03	15	105	2	IPR000679
Domain	OAR	PITX1 PITX2	3.13e-03	15	105	2	PF03826
Domain	GATA	GATA6 GATAD2B	3.13e-03	15	105	2	PF00320
Domain	-	NCOA2 TFEB NCOA1 MGA	3.34e-03	109	105	4	4.10.280.10
Domain	OAR	PITX1 PITX2	3.57e-03	16	105	2	PS50803
Domain	GATA_ZN_FINGER_1	GATA6 GATAD2B	3.57e-03	16	105	2	PS00344
Domain	GATA_ZN_FINGER_2	GATA6 GATAD2B	3.57e-03	16	105	2	PS50114
Domain	OAR_dom	PITX1 PITX2	3.57e-03	16	105	2	IPR003654
Domain	-	ESR2 GATA6 GATAD2B	4.05e-03	57	105	3	3.30.50.10
Domain	Znf_NHR/GATA	ESR2 GATA6 GATAD2B	4.26e-03	58	105	3	IPR013088
Domain	BHLH	NCOA2 TFEB NCOA1 MGA	4.30e-03	117	105	4	PS50888
Domain	bHLH_dom	NCOA2 TFEB NCOA1 MGA	4.43e-03	118	105	4	IPR011598
Domain	-	POU2F2 ISL1 PITX1 PITX2 ZFHX2 PBX1	5.29e-03	283	105	6	1.10.10.60
Domain	USP_CS	USP9X USP9Y USP42	6.11e-03	66	105	3	IPR018200
Domain	LIM	ISL1 ABLIM1 MICAL3	6.91e-03	69	105	3	PF00412
Domain	-	ISL1 ABLIM1 MICAL3	7.19e-03	70	105	3	2.10.110.10
Domain	USP_1	USP9X USP9Y USP42	7.19e-03	70	105	3	PS00972
Domain	Znf_LIM	ISL1 ABLIM1 MICAL3	7.48e-03	71	105	3	IPR001781
Domain	LIM_DOMAIN_1	ISL1 ABLIM1 MICAL3	7.48e-03	71	105	3	PS00478
Domain	UCH	USP9X USP9Y USP42	7.48e-03	71	105	3	PF00443
Pathway	KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY	NCOA2 ESR2 NCOA1	2.22e-05	11	74	3	M47503
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	CDK8 NCOA2 TFEB NCOA6 RAP1GAP TRPC1 GATA6 MYRIP ISL1 MEF2A GATAD2B TRIM33 LIG1 ABLIM1 NEO1 NCOA1 ROBO1 MYOCD MAML2 PBX1	3.27e-05	1432	74	20	M509
Pathway	PID_ERB_GENOMIC_PATHWAY	NCOA2 ESR2 NCOA1	6.04e-05	15	74	3	M119
Pathway	PID_REG_GR_PATHWAY	NCOA2 IRF1 NCOA1 PBX1 MAPK10	6.93e-05	82	74	5	M115
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC12 MUC17	7.40e-05	16	74	3	M27410
Pathway	REACTOME_NETRIN_1_SIGNALING	TRPC1 ABLIM1 NEO1 ROBO1	8.10e-05	44	74	4	M875
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC12 MUC17	8.96e-05	17	74	3	M27412
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	NCOA2 NCOA6 NCOA1	1.07e-04	18	74	3	M26942
Pathway	REACTOME_HEME_SIGNALING	NCOA2 NCOA6 CRTC1 NCOA1	1.24e-04	49	74	4	M41832
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	NCOA2 NCOA6 CRTC1 NCOA1	1.95e-04	55	74	4	M27145
Pathway	REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	NCOA2 NCOA6 SEC24B NCOA1	1.95e-04	55	74	4	M27001
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC12 MUC17	2.28e-04	23	74	3	M556
Pathway	REACTOME_ADIPOGENESIS	CDK8 NCOA2 NCOA6 GATAD2B NCOA1	2.77e-04	110	74	5	M48259
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC12 MUC17	3.31e-04	26	74	3	M27483
Pathway	REACTOME_CARDIOGENESIS	GATA6 ISL1 MYOCD	3.71e-04	27	74	3	M48011
Pathway	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION	NCOA2 NCOA6 NCOA1	3.71e-04	27	74	3	M26943
Pathway	REACTOME_CIRCADIAN_CLOCK	NCOA2 NCOA6 CRTC1 NCOA1	4.94e-04	70	74	4	M938
Pathway	WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY	NCOA2 NCOA6 NCOA1	5.62e-04	31	74	3	M39476
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	CDK8 NCOA2 NCOA6 NCOA1	9.83e-04	84	74	4	M1008
Pathway	WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY	TFEB SALL3 GATA6 DAZL GATAD2B TRIM33 NCOA1	9.99e-04	301	74	7	MM15983
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX6 NCOA2 TFEB HIVEP1 SALL3 EBF3 ESR2 GLIS3 GATA6 IRF1 POU2F2 MEF2A GATAD2B ZCCHC14 ABLIM1 PITX2 NCOA1 MLLT6 KLF17 MGA NFAT5 ZNF292	5.17e-15	808	107	22	20412781
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DOCK4 TFEB NCOA6 RAP1GAP HIVEP1 MAP1B BAG3 CRTC1 FRYL MAP7 RFX7 TRAK1 CEP350 ZCCHC14 PLEKHG1 ABLIM1 SEC24B NAV2 MACF1 PALLD CEP170B GOLGA4	1.87e-14	861	107	22	36931259
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	NCOA2 HIVEP1 EBF3 GATA6 IRF1 POU2F2 ISL1 MEF2A ZCCHC14 ABLIM1 ZNF532 PITX2 ZFAND6 ZFHX2 NCOA1 MACF1 KLF17 PBX1 NFAT5 ZNF292	5.38e-14	709	107	20	22988430
Pubmed	Human transcription factor protein interaction networks.	SOX6 NCOA2 NCOA6 RBM11 XRN2 HIVEP1 SUPT20H USP9X GATA6 IRF1 R3HDM2 MAP7 RFX7 MEF2A GATAD2B TRIM33 PHC3 MIDN UBAP2L SEC24B PITX1 NCOA1 MLLT6 PBX1 MGA	1.17e-12	1429	107	25	35140242
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK4 R3HDM2 TRAK1 ZCCHC14 PLEKHG1 ABLIM1 UBAP2L PDE4DIP NAV3 MACF1 MICAL3 NFAT5 RUBCN CEP170B	3.28e-11	407	107	14	12693553
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SOX6 NCOA2 RBM11 XRN2 RAP1GAP SUPT20H LARP6 USP9X MYRIP USP9Y WAC SCYL2 CEP350 TRIM33 ABLIM1 ZNF532 PDE4DIP NAV3 ROBO1 MACF1 PBX1 ZNF292	4.97e-11	1285	107	22	35914814
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	SECISBP2L TFEB RAP1GAP BCLAF1 USP9X HAUS5 CRTC1 MEF2A MAP3K1 TRAK1 SCYL2 CEP350 TRIM33 ZC3H7A ABLIM1 UBAP2L SEC24B PITX1 C19orf44 EVI5L	5.39e-11	1038	107	20	26673895
Pubmed	A human MAP kinase interactome.	HIVEP1 SUPT20H BAG3 CRTC1 MUC12 CEP350 ZC3H7A ABLIM1 NAV3 NAV2 ROBO1 MACF1 MAPK10 MGA	3.34e-10	486	107	14	20936779
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX6 TFEB HIVEP1 EBF3 ESR2 GATA6 IRF1 POU2F2 ISL1 RFX7 MEF2A PITX1 PITX2 ZFHX2 NCOA1 PBX1 MGA NFAT5	3.53e-10	908	107	18	19274049
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 NCOA6 MAP1B BCLAF1 USP9X HAUS5 BAG3 SCYL2 ABLIM1 UBAP2L SEC24B MGA PALLD	1.54e-08	549	107	13	38280479
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NCOA2 DOCK4 TFEB RBM11 XRN2 HIVEP1 SUPT20H USP9X MAP7 TRIM33 ZC3H7A MACF1 CEP170B	3.43e-08	588	107	13	38580884
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	GATAD2B SCYL2 CEP350 TRIM33 SEC24B MGA PALLD CEP170B	1.10e-07	184	107	8	32908313
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NCOA6 XRN2 HIVEP1 BCLAF1 BAG3 RFX7 GATAD2B LIG1 PHC3 ABLIM1 USP42 UBAP2L MICAL3 GOLGA4	1.17e-07	774	107	14	15302935
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA2 NCOA6 HIVEP1 RFX7 TRIM33 PITX1 PITX2 NCOA1 PBX1 MGA	1.42e-07	351	107	10	38297188
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	CDK8 NCOA2 NCOA6 HIVEP1 MEF2A WAC TRIM33 NCOA1 MGA	1.55e-07	268	107	9	33640491
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	CDK8 NCOA2 NCOA6 XRN2 HIVEP1 EBF3 BCLAF1 MEF2A GATAD2B WAC TRIM33 LIG1 PITX1 NCOA1 MLLT6 ZNF292	2.73e-07	1103	107	16	34189442
Pubmed	Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.	NCOA2 ESR2 NCOA1	2.82e-07	5	107	3	11014206
Pubmed	Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.	NCOA2 ESR2 NCOA1	2.82e-07	5	107	3	11376110
Pubmed	Reduced expression of the LIM-homeobox gene Lhx3 impairs growth and differentiation of Rathke's pouch and increases cell apoptosis during mouse pituitary development.	ISL1 PITX1 PITX2	2.82e-07	5	107	3	16859901
Pubmed	Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.	NCOA2 ESR2 NCOA1	2.82e-07	5	107	3	12554772
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	MAP7 TRAK1 CEP350 ROBO1 MACF1 MICAL3 PALLD CEP170B	2.91e-07	209	107	8	36779422
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	XRN2 FRYL TRAK1 WAC PDE4DIP MACF1 GOLGA4	4.59e-07	151	107	7	17043677
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	XRN2 BCLAF1 USP9X BAG3 MAP7 GATAD2B WAC LIG1 UBAP2L NAV2 PALLD	4.62e-07	503	107	11	16964243
Pubmed	Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines.	NCOA2 ESR2 NCOA1	5.62e-07	6	107	3	12630920
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CDK8 NCOA2 MAP1B MYRIP FRYL LRRC8D MEF2A ABLIM1 ZNF532 UBAP2L ZFHX2 MACF1 MICAL3 PBX1 NFAT5 CEP170B GOLGA4 EVI5L	6.55e-07	1489	107	18	28611215
Pubmed	The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.	NCOA2 ESR2 NCOA1	9.82e-07	7	107	3	9192892
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	NCOA2 SUPT20H MAP1B GATAD2B TRIM33 ABLIM1 UBAP2L SEC24B MGA PALLD	1.21e-06	444	107	10	34795231
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NCOA6 RBM11 XRN2 HIVEP1 SALL3 MAP1B BCLAF1 GATAD2B WAC TRIM33 PHC3 UBAP2L MLLT6 MGA	1.42e-06	954	107	14	36373674
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	DOCK4 SUPT20H MAP1B PODXL CEP350 TRIM33 ABLIM1 USP42 PDE4DIP MLLT6 MAML2 MGA	1.48e-06	689	107	12	36543142
Pubmed	Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes.	NCOA2 ESR2 NCOA1	1.57e-06	8	107	3	12145209
Pubmed	Specification of jaw identity by the Hand2 transcription factor.	ISL1 RB1CC1 PITX1 PBX1	1.64e-06	28	107	4	27329940
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	XRN2 EBF3 BCLAF1 GATA6 RB1CC1 GATAD2B PITX1 PITX2 PBX1 MGA NFAT5	1.94e-06	583	107	11	29844126
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	MAP1B BCLAF1 USP9X SCYL2 ABLIM1 UBAP2L SEC24B ROBO1 MACF1 MICAL3 PALLD GOLGA4	1.96e-06	708	107	12	39231216
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	XRN2 FRYL GATAD2B PDE4DIP MACF1 GOLGA4	2.02e-06	120	107	6	31413325
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	SOX6 USP9X BAG3 GLIS3 SCYL2 TRIM33 PHC3 MACF1	2.76e-06	282	107	8	23667531
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SECISBP2L RAP1GAP TOGARAM1 GATAD2B WAC CEP350 MACF1 MICAL3 MGA PALLD	3.08e-06	493	107	10	15368895
Pubmed	Essential roles of ECAT15-2/Dppa2 in functional lung development.	GATA6 PITX1 PITX2	3.34e-06	10	107	3	21896782
Pubmed	A genomic atlas of mouse hypothalamic development.	EBF3 POU2F2 ISL1 PITX2 NCOA1 ROBO1 PBX1	3.53e-06	205	107	7	20436479
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NCOA2 HIVEP1 SUPT20H GATAD2B TRIM33 PHC3 NCOA1 MGA ZNF292	4.11e-06	398	107	9	35016035
Pubmed	Trim33 is required for appropriate development of pre-cardiogenic mesoderm.	ISL1 MEF2A TRIM33	4.59e-06	11	107	3	30940539
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA2 NCOA6 NCOA1	4.59e-06	11	107	3	36613751
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	PODXL BCLAF1 MUC16 CEP350 TRIM33 LIG1 NEO1 NDC1 SEC24B ROBO1 MGA GOLGA4	5.07e-06	777	107	12	35844135
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CDK8 NCOA2 RBM11 SUPT20H MAP1B BCLAF1 HAUS5 MAP7 CEP350 UBAP2L MICAL3	5.08e-06	645	107	11	25281560
Pubmed	Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase.	MAP1B BCLAF1 USP9X MGA	6.41e-06	39	107	4	25944111
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	MAP1B SCYL2 ZCCHC14 ABLIM1 UBAP2L SEC24B ZFAND6 PALLD	7.29e-06	322	107	8	39098523
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	TFEB GATA6 POU2F2 ISL1 RFX7 PITX1 PITX2 KLF17 PBX1 NFAT5	7.30e-06	544	107	10	28473536
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NCOA6 GLIS3 MAP3K1 PHC3 ZNF469 ZNF532 MLLT6 MAML2 MGA	7.65e-06	430	107	9	35044719
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TFEB NCOA6 ARHGAP26 FRYL TRAK1 ZCCHC14 PLEKHG1 PITX1 NAV2 C19orf44 MLLT6 MICAL3 CEP170B EVI5L	7.68e-06	1105	107	14	35748872
Pubmed	Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140.	NCOA2 ESR2 NCOA1	7.92e-06	13	107	3	11266503
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	NCOA2 HIVEP1 UBAP2L PDE4DIP NCOA1 PHF21B ZNF292	8.17e-06	233	107	7	37704626
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	PODXL USP9X ARHGAP26 MUC16 R3HDM2 PDE4DIP NAV2 ZFHX2 MICAL3 GOLGA4	8.29e-06	552	107	10	10737800
Pubmed	Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.	CRTC1 MAML2	9.38e-06	2	107	2	19269006
Pubmed	Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature.	CRTC1 MAML2	9.38e-06	2	107	2	28343305
Pubmed	Interaction between p230 and MACF1 is associated with transport of a glycosyl phosphatidyl inositol-anchored protein from the Golgi to the cell periphery.	MACF1 GOLGA4	9.38e-06	2	107	2	15265687
Pubmed	Otlx2, an Otx-related homeobox gene expressed in the pituitary gland and in a restricted pattern in the forebrain.	PITX1 PITX2	9.38e-06	2	107	2	9026314
Pubmed	SRC-1 and TIF2 control energy balance between white and brown adipose tissues.	NCOA2 NCOA1	9.38e-06	2	107	2	12507421
Pubmed	Pitx genes during cardiovascular development.	PITX1 PITX2	9.38e-06	2	107	2	12858527
Pubmed	Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.	USP9X PBX1	9.38e-06	2	107	2	30718275
Pubmed	Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens.	CRTC1 MAML2	9.38e-06	2	107	2	36675234
Pubmed	Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome.	USP9X USP9Y	9.38e-06	2	107	2	12895410
Pubmed	Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas.	CRTC1 MAML2	9.38e-06	2	107	2	17334997
Pubmed	Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma.	CRTC1 MAML2	9.38e-06	2	107	2	26796488
Pubmed	Clear cell hidradenoma of the skin-a third tumor type with a t(11;19)--associated TORC1-MAML2 gene fusion.	CRTC1 MAML2	9.38e-06	2	107	2	15729701
Pubmed	Central mucoepidermoid carcinoma, a case report with molecular analysis of the TORC1/MAML2 gene fusion.	CRTC1 MAML2	9.38e-06	2	107	2	20625861
Pubmed	Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction.	NCOA2 NCOA1	9.38e-06	2	107	2	15070739
Pubmed	Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.	ESR2 NCOA1	9.38e-06	2	107	2	10809226
Pubmed	CRTC1/MAML2 fusion transcript in central mucoepidermoid carcinoma of mandible--diagnostic and histogenetic implications.	CRTC1 MAML2	9.38e-06	2	107	2	21074686
Pubmed	Thyroid function in mice with compound heterozygous and homozygous disruptions of SRC-1 and TIF-2 coactivators: evidence for haploinsufficiency.	NCOA2 NCOA1	9.38e-06	2	107	2	11897715
Pubmed	A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas.	CRTC1 MAML2	9.38e-06	2	107	2	20588178
Pubmed	Salivary mucoepidermoid carcinoma revisited.	CRTC1 MAML2	9.38e-06	2	107	2	24771140
Pubmed	Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.	CRTC1 MAML2	9.38e-06	2	107	2	34657306
Pubmed	CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast.	CRTC1 MAML2	9.38e-06	2	107	2	30380176
Pubmed	Distinct steady-state nuclear receptor coregulator complexes exist in vivo.	NCOA2 NCOA1	9.38e-06	2	107	2	9751728
Pubmed	The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2.	USP9X USP9Y	9.38e-06	2	107	2	8922996
Pubmed	Cell-specific activation of the atrial natriuretic factor promoter by PITX2 and MEF2A.	MEF2A PITX2	9.38e-06	2	107	2	15466416
Pubmed	Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis.	NCOA2 NCOA1	9.38e-06	2	107	2	25148457
Pubmed	Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1.	ESR2 NCOA1	9.38e-06	2	107	2	10230404
Pubmed	Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors.	CRTC1 MAML2	9.38e-06	2	107	2	14720503
Pubmed	Usp9y (ubiquitin-specific protease 9 gene on the Y) is associated with a functional promoter and encodes an intact open reading frame homologous to Usp9x that is under selective constraint.	USP9X USP9Y	9.38e-06	2	107	2	12925892
Pubmed	Activation of TORC1 transcriptional coactivator through MEKK1-induced phosphorylation.	CRTC1 MAP3K1	9.38e-06	2	107	2	18784253
Pubmed	Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells.	CRTC1 MAML2	9.38e-06	2	107	2	26503699
Pubmed	The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.	CRTC1 MAML2	9.38e-06	2	107	2	33830080
Pubmed	Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributing to changes in steroid hormone responsiveness.	NCOA2 NCOA1	9.38e-06	2	107	2	15231721
Pubmed	CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior.	CRTC1 MAML2	9.38e-06	2	107	2	17437281
Pubmed	MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma.	CRTC1 MAML2	9.38e-06	2	107	2	16818685
Pubmed	Expression of the members of the Ptx family of transcription factors in human pituitary adenomas.	PITX1 PITX2	9.38e-06	2	107	2	10372733
Pubmed	A closer look at Warthin tumors and the t(11;19).	CRTC1 MAML2	9.38e-06	2	107	2	18206539
Pubmed	Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha.	NCOA6 ESR2 NCOA1	1.01e-05	14	107	3	12039952
Pubmed	Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.	NCOA2 ESR2 NCOA1	1.01e-05	14	107	3	11500849
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	NCOA2 NCOA6 NCOA1	1.01e-05	14	107	3	12482968
Pubmed	Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder.	BCLAF1 RB1CC1 WAC	1.01e-05	14	107	3	28263302
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TFEB NCOA6 XRN2 SUPT20H BCLAF1 GATA6 MAP7 RFX7 GATAD2B WAC PHC3 NDC1 USP42 PITX1 MGA	1.02e-05	1294	107	15	30804502
Pubmed	Stabilization of the methyl-CpG binding protein ZBTB38 by the deubiquitinase USP9X limits the occurrence and toxicity of oxidative stress in human cells.	USP9X BAG3 MAP7 WAC MGA	1.17e-05	95	107	5	29490077
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	CDK8 SALL3 USP9X GATAD2B TRIM33 MGA	1.36e-05	167	107	6	20362541
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	HIVEP1 BCLAF1 BAG3 TOGARAM1 CRTC1 MAP7 MACF1 PALLD	1.66e-05	361	107	8	26167880
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	SOX6 NCOA2 EBF3 ESR2 GLIS3 GATA6 IRF1 ISL1 PITX2 MYOCD PBX1 ZNF292	1.70e-05	877	107	12	20211142
Pubmed	Mutation of p107 exacerbates the consequences of Rb loss in embryonic tissues and causes cardiac and blood vessel defects.	GATA6 ISL1 MYOCD	1.87e-05	17	107	3	19706423
Pubmed	Mechanisms underlying pituitary hypoplasia and failed cell specification in Lhx3-deficient mice.	ISL1 PITX1 PITX2	1.87e-05	17	107	3	18037398
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	KBTBD8 WAC FNDC1 ZNF469 MAML2	2.08e-05	107	107	5	11347906
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	NCOA2 RBM11 PODXL ESR2 GATA6 WAC SCYL2 ZCCHC14 TRIM33 ZFAND6 MICAL3 RUBCN CEP170B PHF21B	2.21e-05	1215	107	14	15146197
Interaction	YWHAH interactions	NCOA2 DOCK4 TFEB NCOA6 RAP1GAP HIVEP1 ESR2 BAG3 CRTC1 R3HDM2 FRYL RB1CC1 MAP7 RFX7 TRAK1 CEP350 ZCCHC14 PLEKHG1 ABLIM1 SEC24B NAV2 NCOA1 MACF1 PALLD RUBCN CEP170B GOLGA4	1.12e-11	1102	106	27	int:YWHAH
Interaction	YWHAG interactions	DOCK4 TFEB NCOA6 RAP1GAP HIVEP1 BCLAF1 ESR2 BAG3 CRTC1 R3HDM2 FRYL RB1CC1 MAP7 RFX7 MAP3K1 TRAK1 CEP350 PLEKHG1 ABLIM1 SEC24B NAV2 MACF1 RUBCN CEP170B	2.33e-08	1248	106	24	int:YWHAG
Interaction	SMAD3 interactions	CDK8 NCOA6 HIVEP1 USP9X ESR2 BAG3 ISL1 ZCCHC14 TRIM33 PITX1 PITX2 NCOA1 MYOCD PBX1	9.38e-08	447	106	14	int:SMAD3
Interaction	SMG7 interactions	SECISBP2L NCOA2 NCOA6 RBM11 XRN2 HIVEP1 R3HDM2 DAZL ZC3H7A UBAP2L NCOA1 MLLT6	1.17e-07	319	106	12	int:SMG7
Interaction	CREBBP interactions	CDK8 NCOA2 NCOA6 HIVEP1 MAP1B ESR2 IRF1 CRTC1 RB1CC1 TRIM33 NCOA1 MAML2 PBX1 MAPK10 MGA	5.60e-07	599	106	15	int:CREBBP
Interaction	SP7 interactions	NCOA2 NCOA6 RBM11 XRN2 HIVEP1 MEF2A TRIM33 PITX1 NCOA1 PBX1 MGA	5.99e-07	304	106	11	int:SP7
Interaction	SYNE3 interactions	DOCK4 TOGARAM1 SCYL2 CEP350 ZCCHC14 PLEKHG1 ABLIM1 NDC1 SEC24B ETAA1 C19orf44 MACF1 CEP170B	6.00e-07	444	106	13	int:SYNE3
Interaction	MYOD1 interactions	NCOA2 HIVEP1 ESR2 MEF2A TRIM33 NCOA1 MYOCD PBX1 MGA	8.66e-07	194	106	9	int:MYOD1
Interaction	YWHAB interactions	DOCK4 TFEB RAP1GAP HIVEP1 ESR2 BAG3 CRTC1 R3HDM2 FRYL RB1CC1 MAP7 RFX7 TRAK1 CEP350 TRIM33 ABLIM1 NAV2 MACF1 CEP170B	1.27e-06	1014	106	19	int:YWHAB
Interaction	GARRE1 interactions	DOCK4 R3HDM2 RB1CC1 SCYL2 PLEKHG1 ZC3H7A UBAP2L SEC24B	2.85e-06	167	106	8	int:GARRE1
Interaction	SOX2 interactions	SOX6 NCOA2 TFEB NCOA6 HIVEP1 SALL3 MAP1B BCLAF1 USP9X ARHGAP26 BAG3 GLIS3 MEF2A GATAD2B SCYL2 TRIM33 PHC3 PITX1 NAV3 NAV2 MACF1 ZNF292	3.90e-06	1422	106	22	int:SOX2
Interaction	YWHAQ interactions	TFEB NCOA6 RAP1GAP ESR2 BAG3 CRTC1 R3HDM2 FRYL MAP7 RFX7 MAP3K1 TRAK1 CEP350 ABLIM1 USP42 NAV2 NCOA1 MACF1 CEP170B	5.29e-06	1118	106	19	int:YWHAQ
Interaction	JUN interactions	NCOA2 NCOA6 EBF3 MEF2A MAP3K1 TRIM33 NCOA1 MACF1 MLLT6 MAPK10 NFAT5 EVI5L	6.81e-06	470	106	12	int:JUN
Interaction	YWHAE interactions	TFEB RAP1GAP HIVEP1 MAP1B ESR2 BAG3 CRTC1 R3HDM2 FRYL RB1CC1 MAP7 MAP3K1 TRAK1 ABLIM1 MIDN NAV2 MACF1 MGA RUBCN CEP170B	7.61e-06	1256	106	20	int:YWHAE
Interaction	SRF interactions	NCOA6 HIVEP1 GATAD2B PHC3 NCOA1 MYOCD ZNF292	8.81e-06	139	106	7	int:SRF
Interaction	FBXO42 interactions	DOCK4 TFEB RBM11 XRN2 HIVEP1 USP9X MAP7 ZC3H7A MACF1	9.23e-06	259	106	9	int:FBXO42
Interaction	PXN interactions	DOCK4 ESR2 BAG3 DAZL SCYL2 CEP350 PLEKHG1 ABLIM1 MACF1 GOLGA4	1.07e-05	334	106	10	int:PXN
Interaction	PFN1 interactions	DOCK4 RBM11 ESR2 BAG3 SCYL2 CEP350 ABLIM1 SEC24B MACF1 MICAL3 PALLD GOLGA4	1.51e-05	509	106	12	int:PFN1
Interaction	FMR1 interactions	NCOA2 MAP1B BCLAF1 USP9X BAG3 DAZL MAP7 ZC3H7A UBAP2L MACF1 CEP170B GOLGA4	2.52e-05	536	106	12	int:FMR1
Interaction	MAPRE3 interactions	DOCK4 MAP7 CEP350 ABLIM1 PDE4DIP NAV2 MACF1 CEP170B	2.94e-05	230	106	8	int:MAPRE3
Interaction	CNOT9 interactions	ESR2 R3HDM2 DAZL CEP350 PLEKHG1 ZC3H7A UBAP2L MGA	3.03e-05	231	106	8	int:CNOT9
Interaction	CEP85 interactions	RBM11 R3HDM2 DAZL MAP3K1 CEP350 ZC3H7A UBAP2L	3.13e-05	169	106	7	int:CEP85
Interaction	GSK3A interactions	BCLAF1 VTA1 MAP7 RFX7 TRAK1 CEP350 ROBO1 MACF1 MICAL3 PALLD CEP170B	3.33e-05	464	106	11	int:GSK3A
Interaction	EGR2 interactions	NCOA2 NCOA6 HIVEP1 TRIM33 PDE4DIP NCOA1 MGA	3.37e-05	171	106	7	int:EGR2
Interaction	MKRN2 interactions	XRN2 MAP1B BCLAF1 R3HDM2 DAZL RB1CC1 ZC3H7A UBAP2L ROBO1 MACF1	3.60e-05	385	106	10	int:MKRN2
Interaction	FOS interactions	NCOA2 NCOA6 HIVEP1 MAP1B TRIM33 MIDN NCOA1 MGA NFAT5	4.01e-05	312	106	9	int:FOS
Interaction	KAT2A interactions	CDK8 TFEB SUPT20H ESR2 IRF1 UBAP2L PBX1	4.67e-05	180	106	7	int:KAT2A
Interaction	ASF1A interactions	SOX6 NCOA6 XRN2 HIVEP1 GATAD2B TRIM33 MLLT6 MGA	5.16e-05	249	106	8	int:ASF1A
Interaction	CIC interactions	SOX6 XRN2 EBF3 BCLAF1 ESR2 GATA6 RB1CC1 GATAD2B PITX1 PITX2 PBX1 MGA NFAT5	5.25e-05	673	106	13	int:CIC
Interaction	R3HDM2 interactions	SECISBP2L R3HDM2 DAZL ZC3H7A UBAP2L SEC24B	6.19e-05	129	106	6	int:R3HDM2
Interaction	HDAC1 interactions	SOX6 RBM11 HIVEP1 ESR2 BAG3 CRTC1 VTA1 RB1CC1 MEF2A GATAD2B TRAK1 PITX2 PBX1 MAPK10 MGA GOLGA4 PHF21B	6.41e-05	1108	106	17	int:HDAC1
Interaction	TOP3B interactions	TFEB NCOA6 RBM11 ARHGAP26 R3HDM2 DAZL FRYL TRAK1 ZCCHC14 PLEKHG1 ZC3H7A UBAP2L SEC24B PITX1 NAV2 C19orf44 MLLT6 MICAL3 CEP170B EVI5L	7.25e-05	1470	106	20	int:TOP3B
Interaction	ZBTB1 interactions	SOX6 BCLAF1 MAP7 GATAD2B TRIM33 PALLD	7.64e-05	134	106	6	int:ZBTB1
Interaction	KLF5 interactions	NCOA2 NCOA6 RBM11 XRN2 HIVEP1 ESR2 MGA	7.74e-05	195	106	7	int:KLF5
Interaction	MAPRE1 interactions	MAP1B BAG3 MAP7 CEP350 ABLIM1 NDC1 PDE4DIP NAV3 NAV2 MACF1 CEP170B	8.36e-05	514	106	11	int:MAPRE1
Interaction	PCM1 interactions	RBM11 USP9X ESR2 HAUS5 RB1CC1 MAP7 CEP350 PLEKHG1 ETAA1 CEP170B	9.77e-05	434	106	10	int:PCM1
Interaction	FEV interactions	NCOA2 NCOA6 HIVEP1 SUPT20H GATA6 PHC3 MGA	9.96e-05	203	106	7	int:FEV
Interaction	TNRC6A interactions	NCOA6 ESR2 R3HDM2 DAZL RB1CC1 ZC3H7A UBAP2L SEC24B	1.17e-04	280	106	8	int:TNRC6A
Interaction	ZBTB38 interactions	USP9X BAG3 MAP7 WAC PDE4DIP MGA	1.18e-04	145	106	6	int:ZBTB38
Interaction	KDM1A interactions	SOX6 RBM11 HIVEP1 USP9X ESR2 BAG3 CRTC1 ISL1 RB1CC1 CEP350 PHC3 ZNF532 PDE4DIP MGA PHF21B	1.19e-04	941	106	15	int:KDM1A
Interaction	PPARA interactions	NCOA2 NCOA6 GATA6 CEP350 NCOA1	1.25e-04	92	106	5	int:PPARA
Interaction	TDRD3 interactions	USP9X ESR2 R3HDM2 DAZL CEP350 ZC3H7A UBAP2L	1.30e-04	212	106	7	int:TDRD3
Interaction	MCRIP2 interactions	R3HDM2 DAZL PHC3 UBAP2L	1.49e-04	51	106	4	int:MCRIP2
Interaction	TLE3 interactions	SOX6 NCOA2 RBM11 HIVEP1 EBF3 WAC PHC3 NCOA1 MLLT6	1.66e-04	376	106	9	int:TLE3
Interaction	MIB1 interactions	USP9X ESR2 ARHGAP26 HAUS5 RB1CC1 SCYL2 MGA PALLD	1.67e-04	295	106	8	int:MIB1
Interaction	MAGED1 interactions	HIVEP1 USP9X ESR2 BAG3 R3HDM2 DAZL ZC3H7A PITX1	1.67e-04	295	106	8	int:MAGED1
Interaction	ERG interactions	SOX6 NCOA2 NCOA6 XRN2 HIVEP1 USP9X TRIM33	1.78e-04	223	106	7	int:ERG
Interaction	GSK3B interactions	MAP1B HAUS5 IRF1 VTA1 MAP7 MAP3K1 TRAK1 CEP350 ROBO1 MACF1 MYOCD MICAL3 PALLD CEP170B	1.81e-04	868	106	14	int:GSK3B
Interaction	SMAD2 interactions	CDK8 NCOA6 USP9X ESR2 MEF2A GATAD2B TRIM33 MYOCD PBX1	1.98e-04	385	106	9	int:SMAD2
Interaction	LSM12 interactions	ESR2 R3HDM2 DAZL ZC3H7A UBAP2L ETAA1	2.31e-04	164	106	6	int:LSM12
Interaction	ZCCHC2 interactions	R3HDM2 DAZL UBAP2L	2.32e-04	23	106	3	int:ZCCHC2
Interaction	PEG10 interactions	MAP1B USP9X R3HDM2 DAZL UBAP2L	2.43e-04	106	106	5	int:PEG10
Interaction	NR2F1 interactions	NCOA2 POU2F2 ISL1 NCOA1	2.47e-04	58	106	4	int:NR2F1
Interaction	NR1H3 interactions	NCOA6 BAG3 CEP350 NCOA1	2.47e-04	58	106	4	int:NR1H3
Interaction	CEBPA interactions	CDK8 NCOA2 NCOA6 XRN2 HIVEP1 EBF3 BCLAF1 MEF2A GATAD2B WAC TRIM33 LIG1 PITX1 NCOA1 MACF1 MLLT6 ZNF292	2.61e-04	1245	106	17	int:CEBPA
Interaction	BRCA1 interactions	CDK8 NCOA2 DOCK4 XRN2 HIVEP1 USP9X ESR2 GATAD2B MAP3K1 CEP350 TRIM33 NDC1 UBAP2L SEC24B ETAA1 NCOA1 PALLD	2.70e-04	1249	106	17	int:BRCA1
Interaction	LARP4B interactions	SECISBP2L BCLAF1 ESR2 DAZL RB1CC1 ZC3H7A UBAP2L	2.79e-04	240	106	7	int:LARP4B
Interaction	SFN interactions	NCOA6 RAP1GAP MAP1B ESR2 FRYL TRAK1 CEP350 ABLIM1 NAV2 MACF1 PALLD CEP170B	2.82e-04	692	106	12	int:SFN
Interaction	ALKBH3 interactions	MAP1B BCLAF1 USP9X MGA	3.00e-04	61	106	4	int:ALKBH3
Interaction	EYA4 interactions	NCOA2 BAG3 R3HDM2 RFX7 SEC24B PITX2 NCOA1	3.01e-04	243	106	7	int:EYA4
Interaction	THRA interactions	CDK8 NCOA2 NCOA6 MEF2A NCOA1	3.02e-04	111	106	5	int:THRA
Interaction	ZYX interactions	SECISBP2L USP9X ESR2 BAG3 CEP350 ABLIM1 MACF1 CEP170B	3.49e-04	329	106	8	int:ZYX
Interaction	PRMT1 interactions	NCOA2 XRN2 MAP1B BCLAF1 USP9X ESR2 DAZL FRYL RB1CC1 MAP7 UBAP2L NCOA1 MGA GOLGA4	3.62e-04	929	106	14	int:PRMT1
Interaction	MAD2L1 interactions	NCOA2 HIVEP1 SUPT20H ESR2 TRIM33 MACF1 MGA	3.74e-04	252	106	7	int:MAD2L1
Interaction	ALG13 interactions	NCOA2 R3HDM2 DAZL ZC3H7A UBAP2L PITX1	4.16e-04	183	106	6	int:ALG13
Interaction	BICC1 interactions	R3HDM2 DAZL UBAP2L	4.21e-04	28	106	3	int:BICC1
Interaction	BAG2 interactions	NCOA2 TFEB NCOA6 MAP1B HAUS5 BAG3 SCYL2 TRIM33 LIG1 PHC3 PALLD	4.34e-04	622	106	11	int:BAG2
Interaction	GOLGA2 interactions	NCOA2 NCOA6 RBM11 HIVEP1 ESR2 GATAD2B TRAK1 ABLIM1 SEC24B PITX1 C19orf44 MLLT6	4.72e-04	733	106	12	int:GOLGA2
Interaction	SMAP2 interactions	R3HDM2 DAZL SCYL2 ZC3H7A UBAP2L SEC24B	4.93e-04	189	106	6	int:SMAP2
Interaction	ASH2L interactions	NCOA6 RBM11 C21orf58 ESR2 MGA GOLGA4 ZNF292	5.06e-04	265	106	7	int:ASH2L
Interaction	HNF1B interactions	SOX6 NCOA2 HIVEP1 BCLAF1 MLLT6 MGA	5.07e-04	190	106	6	int:HNF1B
Interaction	YWHAZ interactions	TFEB RAP1GAP HIVEP1 ESR2 BAG3 CRTC1 R3HDM2 FRYL RB1CC1 MAP7 MAP3K1 TRAK1 ABLIM1 NAV2 MACF1 RUBCN CEP170B	5.07e-04	1319	106	17	int:YWHAZ
Interaction	MED23 interactions	CDK8 NCOA2 NCOA6 SUPT20H ESR2 IRF1 MAP7	5.17e-04	266	106	7	int:MED23
Interaction	POLR1E interactions	RBM11 XRN2 HIVEP1 ESR2 PHC3 MLLT6 MGA ZNF292	5.26e-04	350	106	8	int:POLR1E
Interaction	CDKN2AIPNL interactions	XRN2 BCLAF1 WAC	5.71e-04	31	106	3	int:CDKN2AIPNL
Interaction	CRTC1 interactions	CRTC1 MAP3K1 WAC	5.71e-04	31	106	3	int:CRTC1
GeneFamily	CD molecules\|Mucins	MUC16 MUC12 MUC17	7.03e-05	21	70	3	648
GeneFamily	Ubiquitin specific peptidases	USP9X USP9Y USP42	1.33e-03	56	70	3	366
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	GATA6 GATAD2B	1.50e-03	15	70	2	82
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 NCOA1	1.94e-03	17	70	2	486
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CDK8 SECISBP2L NCOA2 DOCK4 HIVEP1 SUPT20H MAP1B PODXL USP9X TRPC1 TOGARAM1 R3HDM2 FRYL RB1CC1 MEF2A TRAK1 CEP350 TRIM33 SEC24B NAV3 NCOA1 MACF1 MICAL3 GOLGA4 ZNF292	4.11e-15	856	105	25	M4500
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	CDK8 SECISBP2L NCOA6 HIVEP1 LARP6 BAG3 IRF1 RB1CC1 MEF2A WAC ZCCHC14 TRIM33 ZC3H7A SEC24B PDE4DIP NAV2 NCOA1 NFAT5 PALLD	6.40e-10	822	105	19	M6782
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	CDK8 HIVEP1 MAP1B USP9X R3HDM2 FRYL TRAK1 CEP350 TRIM33 SEC24B NCOA1 MICAL3 GOLGA4 ZNF292	5.45e-09	466	105	14	M13522
Coexpression	GABRIELY_MIR21_TARGETS	RFX7 MAP3K1 TRIM33 ZNF532 PBX1 MGA NFAT5 PALLD GOLGA4 ZNF292	2.61e-07	289	105	10	M2196
Coexpression	GSE369_SOCS3_KO_VS_WT_LIVER_DN	SECISBP2L NCOA2 SUPT20H UBALD2 MEF2A MAP3K1 ZFAND6 EVI5L	1.48e-06	200	105	8	M5963
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	XRN2 BCLAF1 USP9X IRF1 POU2F2 FRYL RB1CC1 RFX7 GATAD2B WAC CEP350 TRIM33 PHC3 USP42 PDE4DIP NCOA1 MACF1 MLLT6 NFAT5 ZNF292	1.70e-06	1492	105	20	M40023
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	NCOA6 BCLAF1 FRYL RFX7 WAC ABLIM1 UBAP2L MYOCD PALLD CEP170B GOLGA4	2.83e-06	467	105	11	M1347
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	SECISBP2L DOCK4 HIVEP1 BCLAF1 FRYL RB1CC1 WAC MIDN USP42 UBAP2L NCOA1 GOLGA4 ZNF292	3.36e-06	680	105	13	M41089
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	NCOA6 BCLAF1 FRYL RFX7 WAC ABLIM1 UBAP2L MYOCD PALLD CEP170B GOLGA4	3.97e-06	484	105	11	MM999
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	TRAK1 ZC3H7A PHC3 NAV2 MACF1 MICAL3 NFAT5	4.87e-06	166	105	7	M6826
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA	DOCK4 MAP1B EBF3 MYRIP MUC16 POU2F2 PDE4DIP NAV3 ZFHX2 ROBO1 PBX1	6.06e-06	506	105	11	M39067
Coexpression	OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN	MAP7 TRAK1 WAC TRIM33 ABLIM1 SEC24B NCOA1 NFAT5	6.25e-06	243	105	8	M41178
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	SECISBP2L NCOA6 SUPT20H USP9X LRRC8D MEF2A TRAK1 WAC SCYL2 CEP350 TRIM33 UBAP2L PDE4DIP MACF1 NFAT5 RUBCN GOLGA4	6.51e-06	1215	105	17	M41122
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	SOX6 ARHGAP26 GLIS3 MEF2A ABLIM1 MAML2 MAPK10	7.15e-06	176	105	7	M39223
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	USP9X FRYL RFX7 CEP350 TRIM33 MACF1 NFAT5	8.28e-06	180	105	7	M8239
Coexpression	SHEN_SMARCA2_TARGETS_UP	NCOA6 BCLAF1 USP9X USP9Y CEP350 ZC3H7A SEC24B ZFAND6 NCOA1 MACF1	8.98e-06	429	105	10	M29
Coexpression	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	HIVEP1 LRRC8D MAP3K1 ABLIM1 MACF1 MAML2 NFAT5	1.14e-05	189	105	7	M3112
Coexpression	GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP	R3HDM2 MEF2A MAP3K1 WAC CEP350 PBX1 ZNF292	1.59e-05	199	105	7	M4521
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	DOCK4 ARHGAP26 MEF2A NCOA1 MACF1 PBX1	1.92e-05	137	105	6	M39241
Coexpression	GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP	MEF2A MAP3K1 USP42 SEC24B NAV2 EVI5L	4.77e-05	161	105	6	M7728
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	NCOA2 TFEB ARHGAP26 TRIM33 PDE4DIP MLLT6 MAML2 PBX1	4.82e-05	323	105	8	M9150
Coexpression	ZHAN_MULTIPLE_MYELOMA_MS_UP	LARP6 MYRIP PBX1 PALLD	4.86e-05	50	105	4	M19632
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	GLIS3 MEF2A TRAK1 ABLIM1 NFAT5 PALLD ZNF292	5.25e-05	240	105	7	M39236
Coexpression	ONKEN_UVEAL_MELANOMA_DN	SECISBP2L LRRC8D TRAK1 WAC ABLIM1 ZNF532 ROBO1 PBX1 PALLD GOLGA4	5.70e-05	533	105	10	M2605
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP	KBTBD8 RB1CC1 RFX7 LRRC8D MAP3K1 SCYL2	7.34e-05	174	105	6	M40888
Coexpression	MURARO_PANCREAS_BETA_CELL	MAP1B USP9X BAG3 GLIS3 TOGARAM1 WAC ZCCHC14 NEO1 PDE4DIP NAV2 ROBO1 GOLGA4 ZNF292	1.05e-04	946	105	13	M39169
Coexpression	HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL	LARP6 MUC16 PITX1 PALLD	1.13e-04	62	105	4	M45790
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	DOCK4 MAP1B EBF3 MYRIP POU2F2 PDE4DIP NAV3 ZFHX2 ROBO1 PBX1	1.21e-04	584	105	10	M39068
Coexpression	GARY_CD5_TARGETS_UP	SECISBP2L IRF1 POU2F2 R3HDM2 MEF2A TRAK1 WAC MIDN NFAT5	1.22e-04	473	105	9	M17693
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	DOCK4 TFEB MAP1B GLIS3 WAC PLEKHG1 ABLIM1 NEO1 NAV3 NAV2 MICAL3 RUBCN GOLGA4 PHF21B	1.29e-04	1102	105	14	M2369
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	TFEB NCOA6 R3HDM2 CEP350 TRIM33 MACF1	1.41e-04	196	105	6	M5381
Coexpression	GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP	RBM11 HIVEP1 MEF2A ABLIM1 MAML2 MGA	1.49e-04	198	105	6	M3104
Coexpression	GSE17721_CTRL_VS_LPS_8H_BMDC_DN	NCOA6 POU2F2 CEP350 PITX1 MLLT6 PALLD	1.53e-04	199	105	6	M3700
Coexpression	GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP	NCOA6 EBF3 IRF1 UBALD2 MAP3K1 NCOA1	1.53e-04	199	105	6	M5753
Coexpression	GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN	SECISBP2L DOCK4 IRF1 MLLT6 NFAT5 EVI5L	1.57e-04	200	105	6	M5059
Coexpression	GSE31082_DN_VS_DP_THYMOCYTE_DN	SECISBP2L SUPT20H UBALD2 FRYL ABLIM1 NFAT5	1.57e-04	200	105	6	M5055
Coexpression	GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	CDK8 USP9X ARHGAP26 KBTBD8 MAP3K1 GOLGA4	1.57e-04	200	105	6	M6993
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	DOCK4 TFEB MAP1B GLIS3 WAC PLEKHG1 ABLIM1 NEO1 NAV3 NAV2 MICAL3 RUBCN GOLGA4 PHF21B	1.58e-04	1124	105	14	MM1070
Coexpression	CUI_TCF21_TARGETS_2_DN	SECISBP2L DOCK4 HIVEP1 USP9X TRPC1 ARHGAP26 FRYL PLEKHG1 USP42 PDE4DIP MACF1 PALLD	1.61e-04	854	105	12	M1533
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP	BCLAF1 RB1CC1 RFX7 MAP3K1 SCYL2	1.62e-04	127	105	5	M40905
Coexpression	LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB	SOX6 NCOA2 ABLIM1 MAML2 PBX1	1.87e-04	131	105	5	M39232
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBM	MAP1B EBF3 POU2F2 PDE4DIP PITX2 ROBO1 PHF21B	1.89e-04	295	105	7	M39063
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	SOX6 MEF2A ABLIM1 NAV2 NCOA1 MAML2	1.95e-04	208	105	6	M39233
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	SOX6 DOCK4 PODXL NCOA1 MACF1 PALLD	2.16e-04	212	105	6	M39221
Coexpression	CUI_TCF21_TARGETS_2_DN	SECISBP2L DOCK4 HIVEP1 USP9X TRPC1 ARHGAP26 FRYL PLEKHG1 USP42 PDE4DIP MACF1 PALLD	2.30e-04	888	105	12	MM1018
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL	RBM11 LARP6 MAP1B C21orf58 POU2F2 ISL1 ZFHX2 MICAL3	3.37e-04	429	105	8	M45694
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML1	DOCK4 MAP1B EBF3 POU2F2 PITX2 ROBO1 PHF21B	3.60e-04	328	105	7	M39064
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	DOCK4 TOGARAM1 RB1CC1 NAV3	3.67e-04	84	105	4	M13008
Coexpression	LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR	DOCK4 PODXL ARHGAP26 MEF2A MACF1	3.72e-04	152	105	5	M39243
Coexpression	GHANDHI_DIRECT_IRRADIATION_DN	IRF1 MIDN EVI5L	3.72e-04	35	105	3	M2594
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	DOCK4 TOGARAM1 RB1CC1 NAV3	3.84e-04	85	105	4	M10575
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	TFEB MAP1B EBF3 GLIS3 ISL1 MAP7 LRRC8D ZC3H7A ABLIM1 FNDC1 PITX1 NAV3 NAV2 ZFHX2 NCOA1 MACF1 MAPK10 CEP170B	1.70e-06	984	106	18	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000	SOX6 DOCK4 HIVEP1 MAP1B PODXL USP9X ARHGAP26 GATA6 LRRC8D SCYL2 TRIM33 NEO1 ZNF532 NAV2 ROBO1 CEP170B	3.93e-06	837	106	16	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	SALL3 MAP1B USP9X GLIS3 ISL1 GATAD2B CEP350 ZCCHC14 PLEKHG1 PITX1 PITX2 NAV3 ROBO1 NFAT5	2.87e-05	769	106	14	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	SOX6 NCOA2 NCOA6 SALL3 MAP1B KBTBD8 FRYL MAP7 LRRC8D NAV2 ZFHX2 MICAL3 MAPK10 GOLGA4 PHF21B ZNF292	3.11e-05	989	106	16	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200	MAP1B EBF3 USP9X MYRIP ISL1 MYOCD MAPK10	3.13e-05	178	106	7	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500	MAP1B EBF3 ISL1 MAP7 LRRC8D ABLIM1 PITX1 NAV2 ZFHX2 MACF1 MAPK10	3.74e-05	495	106	11	Facebase_RNAseq_e10.5_Olfactory Pit_500
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000	LARP6 MAP1B EBF3 USP9X KBTBD8 GLIS3 MAP7 LRRC8D GATAD2B CEP350 SEC24B MYOCD MGA NFAT5	4.12e-05	795	106	14	gudmap_developingKidney_e15.5_anlage of loop of Henle_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500	LARP6 MAP1B USP9X MYRIP ISL1 GATAD2B CEP350 ZCCHC14 PITX2 MAPK10	4.47e-05	416	106	10	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	NCOA2 LARP6 MAP1B USP9X MYRIP ISL1 GATAD2B CEP350 ZCCHC14 SEC24B PITX1 PITX2 MYOCD MAPK10	5.60e-05	818	106	14	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_100	MAP1B USP9X PITX1 PITX2 MYOCD	6.01e-05	83	106	5	gudmap_developingLowerUrinaryTract_e14.5_ bladder_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000	MAP1B USP9X GATA6 TOGARAM1 ISL1 SCYL2 ZC3H7A ZNF469 PITX1 PITX2 ETAA1 MYOCD NFAT5 ZNF292	6.22e-05	826	106	14	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_100	GATA6 ISL1 PITX1 PITX2 MYOCD	7.12e-05	86	106	5	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000	MAP1B USP9X ISL1 GATAD2B CEP350 ZCCHC14 NAV3	8.65e-05	209	106	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_500	DOCK4 PODXL BAG3 SCYL2 NEO1 NFAT5	9.96e-05	148	106	6	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	SOX6 NCOA2 SALL3 MAP1B BCLAF1 ISL1 MAP7 LRRC8D TRAK1 CEP350 ZC3H7A MLLT6 MAPK10 RUBCN PHF21B	1.09e-04	983	106	15	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_100	MAP1B ISL1 MYOCD	1.30e-04	20	106	3	gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	NCOA2 LARP6 MAP1B USP9X GATAD2B CEP350 ZCCHC14 SEC24B MYOCD	1.35e-04	385	106	9	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000	MAP1B KBTBD8 ISL1 SCYL2 CEP350 ZNF292	1.38e-04	157	106	6	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#3	TFEB GLIS3 MAP7 PITX1 NAV3 MLLT6 PALLD CEP170B	1.47e-04	305	106	8	Facebase_RNAseq_e9.5_Maxillary Arch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#4	TFEB GLIS3 MAP7 PITX1 NAV3 MLLT6 PALLD CEP170B	1.54e-04	307	106	8	Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#1	TFEB ISL1 PITX1 NAV3 CEP170B	1.67e-04	103	106	5	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K1
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500	SALL3 PODXL KBTBD8 GLIS3 MAP7 ZC3H7A ABLIM1 ZFHX2 MAPK10 PHF21B	1.69e-04	489	106	10	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_200	MAP1B GATA6 ISL1 PITX1 PITX2 MYOCD	1.87e-04	166	106	6	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	SOX6 XRN2 MAP1B WAC TRIM33 LIG1 USP42 MACF1 GOLGA4 PHF21B ZNF292	1.91e-04	595	106	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_200	MAP1B USP9X GATA6 PITX1 PITX2 MYOCD	2.19e-04	171	106	6	gudmap_developingLowerUrinaryTract_e14.5_ bladder_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	SOX6 NCOA2 NCOA6 MAP1B USP9X R3HDM2 RB1CC1 LRRC8D SCYL2 NDC1 MICAL3 GOLGA4 ZNF292	2.55e-04	831	106	13	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000	DOCK4 EBF3 PODXL ARHGAP26 IRF1 DAZL MEF2A PLEKHG1 ZC3H7A ABLIM1 NAV3 MACF1 MAML2	2.55e-04	831	106	13	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500	MAP1B USP9X GATA6 ISL1 ZNF469 PITX1 PITX2 MYOCD NFAT5	2.66e-04	422	106	9	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	SALL3 EBF3 USP9X KBTBD8 TOGARAM1 ISL1 RFX7 NEO1 MIDN PDE4DIP PITX2 ROBO1 ZNF292	2.70e-04	836	106	13	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500	MAP1B EBF3 USP9X MYRIP ISL1 SCYL2 CEP350 MYOCD MAPK10	2.91e-04	427	106	9	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000	DOCK4 MAP1B EBF3 PODXL DAZL FRYL MEF2A PLEKHG1 ZC3H7A ABLIM1 NAV3 ROBO1 MAML2	3.06e-04	847	106	13	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	DOCK4 PODXL USP9X BAG3 GATA6 MUC16 SCYL2 CEP350 NEO1 NAV2 NFAT5 PALLD	3.23e-04	740	106	12	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000	SOX6 DOCK4 HIVEP1 PODXL TRPC1 GATA6 MUC16 SCYL2 NEO1 MIDN NAV2 ROBO1 PALLD	3.46e-04	858	106	13	gudmap_dev gonad_e11.5_F_GonMes_Sma_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000	TFEB SALL3 PODXL KBTBD8 GLIS3 MAP7 ZC3H7A ABLIM1 FNDC1 NAV3 ZFHX2 MAPK10 CEP170B PHF21B	3.52e-04	976	106	14	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	SOX6 MAP1B BCLAF1 FRYL ISL1 LRRC8D TRAK1 FNDC1 ZFHX2 NCOA1 MACF1 MAPK10 PHF21B ZNF292	3.90e-04	986	106	14	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200	MAP1B USP9X ISL1 CEP350	3.95e-04	69	106	4	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	DOCK4 PODXL GATA6 SCYL2 NEO1 NAV2	3.96e-04	191	106	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_1000
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000	BAG3 GATA6 SCYL2 NEO1 NAV2 NFAT5 ZNF292	3.97e-04	268	106	7	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500	MAP1B USP9X GATAD2B SCYL2 CEP350 MYOCD	4.31e-04	194	106	6	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#3	TFEB GLIS3 PITX1 NAV3 CEP170B	4.75e-04	129	106	5	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_500	MAP1B ISL1 MAPK10	4.91e-04	31	106	3	gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k5
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	DOCK4 BCLAF1 ARHGAP26 KBTBD8 GATA6 DAZL RB1CC1 MEF2A UBAP2L NAV2 MGA NFAT5	4.94e-04	776	106	12	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	SOX6 MAP1B BCLAF1 FRYL ISL1 LRRC8D TRAK1 CEP350 ZFHX2 NCOA1 MAPK10 PHF21B EVI5L	5.05e-04	893	106	13	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#1_top-relative-expression-ranked_200	MAP1B ISL1	5.10e-04	7	106	2	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_200_k1
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	HIVEP1 TOGARAM1 WAC TRIM33 LIG1 USP42 UBAP2L SEC24B MACF1 ZNF292	5.24e-04	564	106	10	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3	PODXL KBTBD8 GLIS3 MAP7 ABLIM1 ETAA1 NAV2	5.73e-04	285	106	7	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K3
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	DOCK4 PODXL USP9X BAG3 GATA6 MUC16 SCYL2 NEO1 NAV2 NFAT5 CEP170B ZNF292	5.85e-04	791	106	12	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	DOCK4 PODXL BCLAF1 ARHGAP26 GATA6 DAZL MEF2A MAP3K1 ABLIM1 NAV2 MGA NFAT5	6.12e-04	795	106	12	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#4	TFEB GLIS3 MAP7 PITX1 NAV3 PALLD CEP170B	6.35e-04	290	106	7	Facebase_RNAseq_e10.5_Mandibular Arch_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500	LARP6 MAP1B USP9X GATAD2B CEP350 ZCCHC14	6.38e-04	209	106	6	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100	MAP1B USP9X MYOCD	6.46e-04	34	106	3	gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4	SOX6 MAP1B LRRC8D TRAK1 PHF21B	6.67e-04	139	106	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	SOX6 MAP1B BCLAF1 LRRC8D NCOA1 PHF21B ZNF292	7.45e-04	298	106	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_1000	DOCK4 EBF3 PODXL IRF1 DAZL UBALD2 MEF2A PLEKHG1 ZC3H7A NAV3 ROBO1 MAML2	7.77e-04	817	106	12	gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_1000	DOCK4 PODXL GATA6 SCYL2 NEO1 NAV2 NFAT5	7.90e-04	301	106	7	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500	SOX6 SALL3 MAP1B BCLAF1 ISL1 MAP7 LRRC8D MAPK10 PHF21B	8.17e-04	493	106	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlas	facebase_RNAseq_e10.5_OlfacPit_2500	MAP1B EBF3 TRPC1 GLIS3 MYRIP ISL1 MAP7 LRRC8D PLEKHG1 ABLIM1 PITX2 ETAA1 NAV2 ZFHX2 PBX1 CEP170B PHF21B	8.38e-04	1453	106	17	facebase_RNAseq_e10.5_OlfacPit_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500	SOX6 MAP1B FRYL ISL1 LRRC8D TRAK1 ZFHX2 MAPK10 PHF21B	8.53e-04	496	106	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#2_top-relative-expression-ranked_500	DOCK4 PODXL GATA6 SCYL2 NEO1	8.59e-04	147	106	5	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k2_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	SOX6 SALL3 MAP1B FRYL MAP7 LRRC8D MAPK10 GOLGA4 PHF21B	8.77e-04	498	106	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#2_top-relative-expression-ranked_500	GATA6 ZNF469 PITX1 PITX2	9.10e-04	86	106	4	gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	MAP1B GATAD2B CEP350 MYOCD NFAT5	9.13e-04	149	106	5	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	DOCK4 HIVEP1 PODXL GATA6 SCYL2 NEO1	9.15e-04	224	106	6	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000	BCLAF1 GATA6 UBAP2L MGA NFAT5	9.40e-04	150	106	5	gudmap_developingGonad_e12.5_ovary_k4_1000
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500	DOCK4 PODXL BAG3 GATA6 SCYL2 NEO1 NAV2 NFAT5	9.54e-04	404	106	8	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	TFEB SALL3 GLIS3 MAP7 PITX1 PALLD CEP170B	9.56e-04	311	106	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#3	TFEB GLIS3 MAP7 PITX1 MLLT6 PALLD CEP170B	9.56e-04	311	106	7	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000	LARP6 MAP1B PODXL GATA6 ISL1 ZCCHC14 FNDC1 PITX1 PITX2 ETAA1 MYOCD ZNF292	9.58e-04	837	106	12	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	NCOA2 MAP1B USP9X GATAD2B CEP350 MYOCD NFAT5	9.74e-04	312	106	7	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#5	TFEB GLIS3 MAP7 NAV3 CEP170B	9.98e-04	152	106	5	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K5
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000	SUPT20H EBF3 BCLAF1 GATA6 ISL1 WAC NDC1 UBAP2L SEC24B PITX2 MGA NFAT5	1.03e-03	844	106	12	gudmap_developingGonad_e11.5_testes and mesonephros_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000	TFEB EBF3 GLIS3 UBALD2 ISL1 ZC3H7A FNDC1 PITX2 NAV3 NCOA1 MAPK10 CEP170B EVI5L	1.05e-03	967	106	13	Facebase_RNAseq_e9.5_Maxillary Arch_1000
CoexpressionAtlas	Myeloid Cells, DC.IIhilang+103-11b+.SLN, MHCIIhi CD11c+ Langerin+ CD103- CD11b+, Lymph Node, avg-3	HIVEP1 IRF1 CEP350 PLEKHG1 ZFAND6 MICAL3 PBX1 NFAT5	1.06e-03	411	106	8	GSM538271_500
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_induced-Mesoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000	RBM11 SALL3 PODXL PCDHB5 GATA6 MYRIP ISL1 MAP7 NEO1 PITX2 NPAP1 MYOCD PHF21B	1.07e-03	969	106	13	PCBC_MESO-5_blastocyst_1000
CoexpressionAtlas	kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000	DOCK4 PODXL ARHGAP26 IRF1 LRRC8D MEF2A PLEKHG1 ZC3H7A PHC3 MACF1 PBX1 NFAT5	1.09e-03	850	106	12	gudmap_kidney_adult_RenMedVasc_Tie2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_500	MAP1B USP9X MYOCD NFAT5	1.17e-03	92	106	4	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_500
CoexpressionAtlas	dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000	DOCK4 PODXL MEF2A	1.20e-03	42	106	3	gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k4_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_500	MAP1B PODXL GATA6 ISL1 ZCCHC14 PITX1 PITX2 MYOCD	1.22e-03	420	106	8	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000	MAP1B PODXL KBTBD8 GLIS3 UBALD2 MAP7 TRAK1 PLEKHG1 ABLIM1 ETAA1 NAV2 MAPK10 PHF21B	1.32e-03	991	106	13	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	NCOA6 RAP1GAP EBF3 PODXL BCLAF1 USP9X ARHGAP26 RB1CC1 WAC TRIM33 ZC3H7A PHC3 UBAP2L ETAA1 ZNF292	1.38e-03	1252	106	15	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500	EBF3 USP9X KBTBD8 ISL1 RFX7 PITX2 ROBO1 ZNF292	1.40e-03	429	106	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500	MAP1B USP9X SCYL2 CEP350 MYOCD	1.44e-03	165	106	5	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#4	TFEB GLIS3 MAP7 PITX1 MLLT6 PALLD CEP170B	1.44e-03	334	106	7	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K4
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	SECISBP2L SOX6 MAP1B USP9X ARHGAP26 GATA6 MAP7 MEF2A MAP3K1 NAV2 ROBO1 MICAL3	1.47e-03	880	106	12	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200	MAP1B USP9X ISL1 CEP350 MAPK10	1.48e-03	166	106	5	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200
CoexpressionAtlas	alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1	TOGARAM1 CEP350 ABLIM1 CD226 MACF1 MAML2 ZNF292	1.49e-03	336	106	7	GSM538413_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_200	EBF3 MYRIP ISL1 PITX2 MAPK10	1.52e-03	167	106	5	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500	SUPT20H EBF3 BCLAF1 ISL1 NDC1 UBAP2L SEC24B MGA	1.53e-03	435	106	8	gudmap_developingGonad_e11.5_testes and mesonephros_500
CoexpressionAtlas	ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_100	EBF3 GATA6 PITX1 PITX2	1.59e-03	100	106	4	PCBC_ratio_EB_vs_SC_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000	LARP6 MAP1B ISL1 MYOCD	1.65e-03	101	106	4	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2	MAP1B ISL1 LRRC8D TRAK1 CEP350 ZFHX2 NCOA1 MACF1 MAPK10 EVI5L	1.70e-03	659	106	10	Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	NCOA2 NCOA6 USP9X R3HDM2 RB1CC1 WAC SCYL2 ZC3H7A NDC1 MACF1 MICAL3	1.79e-03	780	106	11	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274	SALL3 EBF3 USP9X TOGARAM1 PDE4DIP ZNF292	1.81e-03	256	106	6	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#4_top-relative-expression-ranked_1000	ARHGAP26 IRF1 MEF2A ZC3H7A PHC3 MAML2	1.88e-03	258	106	6	gudmap_kidney_adult_Mesangium_Meis_k4_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_200	MAP1B MYRIP MAPK10	1.89e-03	49	106	3	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#1	TFEB MAP7 PITX1 NAV3 NAV2 CEP170B	1.92e-03	259	106	6	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K1
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B USP9X FRYL NAV2 NCOA1 MACF1 MGA GOLGA4	2.44e-08	195	107	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B USP9X FRYL NAV2 NCOA1 MACF1 MGA GOLGA4	2.44e-08	195	107	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Interneuron\|1m / Sample Type, Dataset, Time_group, and Cell type.	MAP1B EBF3 POU2F2 ISL1 CEP350 PITX1 PBX1 PHF21B	2.96e-08	200	107	8	fc839e9c33ea1d4ee0f42f21fd32a54e7cbe1f5a
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	DOCK4 NAV3 NAV2 ROBO1 MACF1 PBX1 PALLD	3.52e-07	187	107	7	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	XRN2 MAP3K1 ZC3H7A ABLIM1 USP42 MACF1 ZNF292	3.91e-07	190	107	7	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	HIVEP1 POU2F2 MEF2A TRAK1 PLEKHG1 MICAL3 RUBCN	3.91e-07	190	107	7	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	XRN2 HIVEP1 RB1CC1 ROBO1 NFAT5 GOLGA4 ZNF292	4.20e-07	192	107	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SOX6 EBF3 ISL1 PLEKHG1 ROBO1 PBX1 MAPK10	4.20e-07	192	107	7	d0649410cf5eacdb0c1dce70e37c7473ef5fddfa
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK4 NAV3 NAV2 ROBO1 MACF1 PBX1 PALLD	4.35e-07	193	107	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	XRN2 HIVEP1 RB1CC1 ROBO1 NFAT5 GOLGA4 ZNF292	4.35e-07	193	107	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IRF1 MEF2A MAP3K1 TRAK1 PLEKHG1 MICAL3 RUBCN	4.50e-07	194	107	7	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L POU2F2 MEF2A MAP3K1 TRAK1 PLEKHG1 MICAL3	4.66e-07	195	107	7	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L POU2F2 MEF2A MAP3K1 TRAK1 PLEKHG1 MICAL3	4.66e-07	195	107	7	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 DOCK4 RFX7 NAV2 NCOA1 MAML2 MAPK10	4.83e-07	196	107	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DOCK4 NEO1 NAV2 MACF1 MICAL3 PBX1 PALLD	4.83e-07	196	107	7	54f4cf778f95a9ff662e5c7520916a25e605bf95
ToppCell	RV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ABLIM1 PDE4DIP KLF17 MYOCD MICAL3 PALLD	5.07e-07	122	107	6	1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 DOCK4 GLIS3 NAV2 NCOA1 MAML2 MAPK10	5.17e-07	198	107	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FRYL USP9Y PHC3 CD226 MACF1 GOLGA4 ZNF292	5.35e-07	199	107	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	BCLAF1 GLIS3 RB1CC1 CEP350 PBX1 GOLGA4 ZNF292	5.35e-07	199	107	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PODXL ARHGAP26 MYRIP PLEKHG1 NAV3	4.72e-06	179	107	6	8f9e538c822940785130297712b75131812a4603
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B EBF3 GATA6 FNDC1 NAV3 PALLD	5.03e-06	181	107	6	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B EBF3 GATA6 FNDC1 NAV3 PALLD	5.03e-06	181	107	6	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XRN2 BCLAF1 MEF2A CEP350 MACF1 GOLGA4	5.53e-06	184	107	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	POU2F2 MAP3K1 TRAK1 MIDN ZFAND6 MICAL3	5.89e-06	186	107	6	55b239834b96b1f7787ec77a7d19796d617bbbf0
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	NCOA2 MAP3K1 CEP350 TRIM33 PHC3 NFAT5	5.89e-06	186	107	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	BCLAF1 USP9X ARHGAP26 RB1CC1 MACF1 NFAT5	6.26e-06	188	107	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SALL3 PODXL ARHGAP26 MYRIP ABLIM1 PBX1	6.45e-06	189	107	6	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DOCK4 NEO1 NAV2 MACF1 PBX1 PALLD	6.45e-06	189	107	6	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SOX6 NCOA2 MAML2 PBX1 MAPK10 NFAT5	6.45e-06	189	107	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	CTRL-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	TFEB POU2F2 MEF2A TRAK1 PLEKHG1 MICAL3	6.45e-06	189	107	6	14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DOCK4 NEO1 NAV2 MACF1 PBX1 PALLD	6.65e-06	190	107	6	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	DOCK4 NEO1 MACF1 MICAL3 PBX1 PALLD	6.85e-06	191	107	6	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DOCK4 NEO1 NAV2 MACF1 MICAL3 PALLD	6.85e-06	191	107	6	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NAV3 NAV2 ROBO1 MACF1 PBX1 PALLD	6.85e-06	191	107	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NAV3 NAV2 ROBO1 MACF1 PBX1 PALLD	7.06e-06	192	107	6	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NEO1 NAV2 MACF1 MICAL3 PBX1 PALLD	7.06e-06	192	107	6	2802fae55683345ff94a1ecf73b6fbee4f17481e
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP9X ARHGAP26 MEF2A CEP350 MACF1 PBX1	7.06e-06	192	107	6	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SOX6 GLIS3 MACF1 MAML2 MAPK10 GOLGA4	7.06e-06	192	107	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PODXL ARHGAP26 PLEKHG1 NAV3 PBX1	7.06e-06	192	107	6	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	BCLAF1 USP9X FRYL CEP350 TRIM33 MGA	7.27e-06	193	107	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX6 GLIS3 MAP7 ABLIM1 MAPK10 GOLGA4	7.27e-06	193	107	6	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	LA\|World / Chamber and Cluster_Paper	MAP1B GLIS3 NAV2 ROBO1 MAML2 MAPK10	7.27e-06	193	107	6	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	CF-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	TFEB POU2F2 MEF2A TRAK1 PLEKHG1 MICAL3	7.27e-06	193	107	6	7ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PODXL ARHGAP26 PLEKHG1 NAV3 PBX1	7.27e-06	193	107	6	52e918884877b6659cdca0496390e440f73694a9
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK4 PDE4DIP NAV3 NAV2 PBX1 PALLD	7.49e-06	194	107	6	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TFEB POU2F2 MEF2A MAP3K1 MICAL3 MAPK10	7.49e-06	194	107	6	f0c113edb706d53792892115b67277a285219942
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PODXL ARHGAP26 MYRIP PLEKHG1 PBX1	7.49e-06	194	107	6	fa6d51f36a3dae8763a595c20892987ed454c0f0
ToppCell	Control-Multiplet\|Control / Disease state, Lineage and Cell class	GLIS3 GATA6 ABLIM1 NAV2 PBX1 MAPK10	7.71e-06	195	107	6	618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B NEO1 PITX1 MYOCD MAPK10 PALLD	7.71e-06	195	107	6	eb2003d4f15cad213d17eda8ab7479f5a0c62164
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	GLIS3 NAV2 ROBO1 MAML2 PBX1 MAPK10	7.71e-06	195	107	6	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	Control-Multiplet-Multiplet\|Control / Disease state, Lineage and Cell class	GLIS3 GATA6 ABLIM1 NAV2 PBX1 MAPK10	7.71e-06	195	107	6	06ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PODXL ARHGAP26 PLEKHG1 NAV3 PBX1	7.94e-06	196	107	6	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PODXL MYRIP PLEKHG1 NAV3 PBX1	7.94e-06	196	107	6	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK4 GLIS3 ROBO1 MACF1 MAML2 PBX1	7.94e-06	196	107	6	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PODXL MYRIP PLEKHG1 NAV3 PBX1	7.94e-06	196	107	6	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	mild_COVID-19_(asymptomatic)\|World / disease group, cell group and cell class (v2)	TFEB POU2F2 MEF2A MAP3K1 ZC3H7A ZFAND6	7.94e-06	196	107	6	8cb3dcb3e5732f4bb060c87ca339b8997a1a8cd4
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NAV3 NAV2 ROBO1 MACF1 PBX1 PALLD	7.94e-06	196	107	6	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	SOX6 SALL3 GLIS3 IRF1 FNDC1 PALLD	8.17e-06	197	107	6	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EBF3 BAG3 IRF1 ISL1 NAV3 PBX1	8.17e-06	197	107	6	05e303fff86db31f7b742324c64980eb2b9cff9a
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	SOX6 SALL3 GLIS3 IRF1 FNDC1 PALLD	8.17e-06	197	107	6	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	DOCK4 NEO1 ROBO1 MACF1 MAPK10 PALLD	8.17e-06	197	107	6	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GLIS3 GATA6 NAV2 ROBO1 MAML2 PALLD	8.41e-06	198	107	6	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	IPF-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	DOCK4 ESR2 MYRIP NAV3 NAV2 ROBO1	8.41e-06	198	107	6	b8bd1ba268480f54451648e01631b615a3401144
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EBF3 BAG3 IRF1 ISL1 NAV3 PBX1	8.41e-06	198	107	6	cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	BCLAF1 RB1CC1 CEP350 TRIM33 PBX1 GOLGA4	8.41e-06	198	107	6	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NAV3 NAV2 ROBO1 MACF1 PBX1 PALLD	8.41e-06	198	107	6	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PODXL ARHGAP26 PLEKHG1 NAV3 PBX1	8.41e-06	198	107	6	0a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	MAP1B BCLAF1 TRIM33 PDE4DIP PBX1 ZNF292	8.41e-06	198	107	6	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	BCLAF1 GLIS3 TOGARAM1 RB1CC1 CEP350 GOLGA4	8.66e-06	199	107	6	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	MAP1B BCLAF1 RB1CC1 CEP350 GOLGA4 ZNF292	8.66e-06	199	107	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BCLAF1 FRYL CEP350 MACF1 GOLGA4 ZNF292	8.91e-06	200	107	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	mild-B_intermediate\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	POU2F2 MEF2A TRAK1 PLEKHG1 MICAL3 MAPK10	8.91e-06	200	107	6	fe815824e9e4be3f3db73610e3814a7fd533da65
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	BCLAF1 IRF1 POU2F2 MIDN GOLGA4 ZNF292	8.91e-06	200	107	6	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-5\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HAUS5 POU2F2 PLEKHG1 ZNF469 ZNF532	3.99e-05	158	107	5	41cf950983f47a9e55d56041b301006b42853b37
ToppCell	Endothelial-endothelial_cell_of_bronchial_vessel\|World / Lineage, Cell type, age group and donor	EBF3 PODXL MYRIP PLEKHG1 NAV3	4.91e-05	165	107	5	84e553d699ac56df89a77248f7308b9133e1b683
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	MAP1B FNDC1 MYOCD MICAL3 PALLD	6.14e-05	173	107	5	a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SOX6 MAP1B MYOCD MICAL3 PBX1	6.14e-05	173	107	5	5416b092321c7d9b63f0418c60f2402a138355bf
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAV2 ROBO1 MACF1 MAML2 PALLD	6.49e-05	175	107	5	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GLIS3 GATA6 NAV2 ROBO1 MAML2	6.49e-05	175	107	5	910a075ccaf79de22338ecf321fa0a867f3d7d75
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GLIS3 GATA6 NAV2 ROBO1 MAML2	6.49e-05	175	107	5	f0c2eb82e17e8aec2cfa5d83169178f409cc1abc
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEF2A MAP3K1 NAV3 MACF1 MAML2	6.49e-05	175	107	5	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SUPT20H GATA6 CEP350 MACF1 MYOCD	6.66e-05	176	107	5	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PODXL PLEKHG1 NAV3 MACF1 NFAT5	7.03e-05	178	107	5	ad3de3e03a401dac64431a541899445262246347
ToppCell	COVID-19-kidney-Stressed_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK4 PODXL ARHGAP26 BAG3 PLEKHG1	7.22e-05	179	107	5	754f69bac7a1d5137f5141f6193285ccbfe361cb
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PODXL ESR2 FRYL PLEKHG1 ABLIM1	7.22e-05	179	107	5	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK4 PODXL ARHGAP26 PLEKHG1 MACF1	7.41e-05	180	107	5	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL ISL1 MEF2A PLEKHG1 MACF1	7.41e-05	180	107	5	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAP1B EBF3 ESR2 GATA6 FRYL	7.41e-05	180	107	5	67c5068b660cd5e727a665cefe3bd5f8ae887221
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL ISL1 MEF2A PLEKHG1 MACF1	7.41e-05	180	107	5	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B POU2F2 ZFHX2 MAPK10 PHF21B	7.41e-05	180	107	5	368ff7fcfd21ad248f96a83a8b191040ba7d8670
ToppCell	facs-Kidney-nan-3m\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP MAP1B USP9X MIDN PBX1	7.81e-05	182	107	5	4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PODXL ZNF469 ROBO1 PBX1	8.01e-05	183	107	5	dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	USP9X IRF1 CEP350 NFAT5 ZNF292	8.01e-05	183	107	5	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 PODXL ZNF469 ROBO1 PBX1	8.01e-05	183	107	5	4759560e5b4f4e5a00e5f933e3451a27c7c4aefe
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 ARHGAP26 PLEKHG1 NAV3 PBX1	8.22e-05	184	107	5	688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP3K1 ABLIM1 CD226 MACF1 RUBCN	8.22e-05	184	107	5	b12fb85a064f715a4f0ada1df8e422c359b573cf
ToppCell	facs-Marrow-T-cells-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP3K1 ABLIM1 CD226 MACF1 RUBCN	8.43e-05	185	107	5	e1fd0a807def8c2127194108b1a30c6de7024292
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SOX6 MAP1B EBF3 GLIS3 ROBO1	8.43e-05	185	107	5	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	FRYL NDC1 MACF1 NFAT5 ZNF292	8.43e-05	185	107	5	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP1 MAP1B USP9X BAG3 TRAK1	8.43e-05	185	107	5	eb7d3c1363d5fedc611f9c1a91ea823de251355e
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	CDK8 NCOA2 FRYL MAP7 MEF2A SCYL2 CEP350 TRIM33 SEC24B MGA	1.44e-08	183	106	10	7498_DN
Drug	2',3',4',5'-tetrachloro-4-biphenylol	NCOA2 ESR2 NCOA1	1.94e-06	6	106	3	ctd:C104006
Drug	Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SECISBP2L MAP1B TRAK1 PHC3 ABLIM1 PDE4DIP PITX2 NFAT5	4.13e-06	198	106	8	2898_DN
Drug	Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	SUPT20H TRPC1 ARHGAP26 MAP3K1 ZCCHC14 PITX1 PDE4DIP NCOA1	4.13e-06	198	106	8	4970_DN
Drug	pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A	DOCK4 SUPT20H MAP1B ARHGAP26 MEF2A PDE4DIP ETAA1 NFAT5	4.13e-06	198	106	8	7083_UP
Drug	Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A	SECISBP2L TRPC1 ARHGAP26 MEF2A TRAK1 PBX1 CEP170B ZNF292	4.45e-06	200	106	8	7129_DN
Drug	Asbestos, Crocidolite	DOCK4 HIVEP1 LARP6 ARHGAP26 GLIS3 GATA6 CRTC1 LRRC8D PHC3 PDE4DIP NAV3 NAV2 NCOA1 ROBO1 MYOCD MAML2 PBX1 NFAT5	1.60e-05	1241	106	18	ctd:D017638
Drug	Succimer	NCOA2 XRN2 HIVEP1 BCLAF1 USP9X POU2F2 RFX7 MEF2A PHC3 ABLIM1 NDC1 UBAP2L PDE4DIP NAV2 MGA NFAT5 GOLGA4 ZNF292	2.04e-05	1264	106	18	ctd:D004113
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	NCOA2 TOGARAM1 WAC CEP350 TRIM33 SEC24B MGA	2.33e-05	182	106	7	3887_DN
Drug	AC1L9M2J	NCOA2 ESR2 POU2F2 RB1CC1 NCOA1	2.83e-05	76	106	5	CID000448538
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	SECISBP2L NCOA2 MAP1B CEP350 ABLIM1 NFAT5 ZNF292	3.17e-05	191	106	7	4279_DN
Drug	Magnetite Nanoparticles	NCOA2 XRN2 HIVEP1 BCLAF1 USP9X POU2F2 RFX7 MEF2A PHC3 ABLIM1 NDC1 UBAP2L PDE4DIP NAV2 MGA NFAT5 GOLGA4 ZNF292	3.28e-05	1310	106	18	ctd:D058185
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SUPT20H CRTC1 MAP3K1 TRAK1 PHC3 PDE4DIP PITX2	3.39e-05	193	106	7	5629_DN
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	DOCK4 LARP6 CRTC1 PDE4DIP ROBO1 MICAL3 NFAT5	3.39e-05	193	106	7	5024_DN
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A	RAP1GAP HIVEP1 NEO1 UBAP2L NCOA1 MGA ZNF292	3.39e-05	193	106	7	6215_DN
Drug	calmidazolium chloride; Down 200; 5uM; MCF7; HT_HG-U133A_EA	SUPT20H HAUS5 TRIM33 ABLIM1 UBAP2L ETAA1 ROBO1	3.50e-05	194	106	7	906_DN
Drug	Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A	SECISBP2L DOCK4 TRPC1 ETAA1 NAV3 NAV2 RUBCN	3.50e-05	194	106	7	4662_DN
Drug	Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A	NCOA2 MAP1B TRPC1 ARHGAP26 IRF1 LRRC8D MICAL3	3.50e-05	194	106	7	5293_UP
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A	ARHGAP26 RB1CC1 MAP7 RFX7 LIG1 PHC3 MAPK10	3.62e-05	195	106	7	5878_UP
Drug	Trioxsalen [3902-71-4]; Down 200; 17.6uM; PC3; HT_HG-U133A	GATA6 CRTC1 ZCCHC14 UBAP2L PITX1 PDE4DIP NAV3	3.62e-05	195	106	7	5736_DN
Drug	Iocetamic acid [16034-77-8]; Up 200; 6.6uM; PC3; HT_HG-U133A	NCOA2 ARHGAP26 MAP7 MAP3K1 NEO1 PITX1 PDE4DIP	3.74e-05	196	106	7	4600_UP
Drug	Ethosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A	SUPT20H TRPC1 HAUS5 MAP7 WAC CEP350 UBAP2L	3.86e-05	197	106	7	2116_DN
Drug	Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; PC3; HT_HG-U133A	SECISBP2L MAP1B SCYL2 PDE4DIP ZFHX2 PBX1 NFAT5	3.86e-05	197	106	7	2110_UP
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A	SUPT20H TRPC1 ISL1 TRAK1 ABLIM1 CEP170B ZNF292	3.86e-05	197	106	7	1810_DN
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	GATA6 RB1CC1 MAP3K1 TRAK1 PITX1 ETAA1 ROBO1	3.86e-05	197	106	7	5564_DN
Drug	Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; PC3; HT_HG-U133A	CRTC1 MAP7 USP9Y RFX7 CEP350 PDE4DIP PBX1	3.99e-05	198	106	7	6332_UP
Drug	quercetin dihydrate; Down 200; 1uM; MCF7; HT_HG-U133A_EA	SUPT20H MEF2A TRIM33 ABLIM1 UBAP2L ROBO1 ZNF292	3.99e-05	198	106	7	917_DN
Drug	Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A	SECISBP2L LARP6 MAP1B IRF1 TRAK1 PDE4DIP NCOA1	4.12e-05	199	106	7	3307_DN
Drug	Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; PC3; HT_HG-U133A	TOGARAM1 CRTC1 MAP7 RFX7 MEF2A PDE4DIP ZFHX2	4.12e-05	199	106	7	5753_DN
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	NCOA2 DOCK4 ARHGAP26 CRTC1 PHC3 PITX1 ETAA1	4.25e-05	200	106	7	2323_DN
Drug	ferutinin	NCOA2 ESR2 NCOA1	5.26e-05	16	106	3	CID000354654
Drug	geldanamycin	NCOA2 MAP1B FRYL RFX7 MAP3K1 SCYL2 PDE4DIP MYOCD NFAT5	6.01e-05	371	106	9	ctd:C001277
Drug	raloxifene core	NCOA6 ESR2	6.42e-05	3	106	2	CID000445920
Drug	premix	NCOA6 BCLAF1 NAV3	9.00e-05	19	106	3	CID000013836
Drug	AC1L2E0P	NCOA2 NCOA6 ESR2 ISL1 TRIM33 NCOA1 MLLT6 MAPK10	9.58e-05	307	106	8	CID000019390
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	NCOA2 TRIM33 SEC24B NAV2 NCOA1 MGA	1.51e-04	171	106	6	7535_DN
Drug	Ala-Val-Gly	NCOA6 ARHGAP26 ROBO1	1.85e-04	24	106	3	CID000452666
Drug	retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A	RAP1GAP IRF1 TRAK1 CEP350 NAV2 PBX1	1.88e-04	178	106	6	1636_UP
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	SECISBP2L WAC SCYL2 CEP350 ABLIM1 NFAT5	1.88e-04	178	106	6	3998_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	WAC CEP350 TRIM33 SEC24B NAV2 ZNF292	1.99e-04	180	106	6	4541_DN
Drug	iclaprim	NCOA2 ESR2 NCOA1 MAPK10	2.01e-04	62	106	4	CID000213043
Drug	dioxybenzone	NCOA2 ESR2	2.13e-04	5	106	2	ctd:C004839
Drug	3-benzylidene camphor	ESR2 NCOA1	2.13e-04	5	106	2	ctd:C511303
Drug	4-ethoxymethylphenol	ESR2 NCOA1	2.13e-04	5	106	2	CID000093781
Drug	MF101 extract	NCOA2 ESR2	2.13e-04	5	106	2	ctd:C517398
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	NCOA2 CEP350 TRIM33 SEC24B MGA ZNF292	2.24e-04	184	106	6	2321_DN
Drug	retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A	RAP1GAP SUPT20H ESR2 IRF1 PDE4DIP NAV2	2.31e-04	185	106	6	6971_UP
Drug	retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A	RAP1GAP MAP3K1 TRAK1 PDE4DIP NAV2 ROBO1	2.31e-04	185	106	6	6931_UP
Drug	cyclosulfamuron	NCOA2 ESR2 NCOA1 MAPK10	2.42e-04	65	106	4	CID006451137
Drug	carmustine; Up 200; 100uM; PC3; HT_HG-U133A	SUPT20H MAP1B HAUS5 TRAK1 PHC3 NFAT5	2.45e-04	187	106	6	6883_UP
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	SECISBP2L WAC SCYL2 CEP350 ABLIM1 NFAT5	2.52e-04	188	106	6	6735_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; HL60; HT_HG-U133A	SECISBP2L DOCK4 RAP1GAP GATA6 PDE4DIP NCOA1	2.52e-04	188	106	6	1150_UP
Drug	androstenol	NCOA2 NCOA6 NCOA1	2.64e-04	27	106	3	CID000101989
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A	SECISBP2L NCOA2 MAP1B RFX7 PDE4DIP NFAT5	2.67e-04	190	106	6	4507_DN
Drug	Tetrahydrozoline hydrochloride [522-48-5]; Down 200; 16.8uM; MCF7; HT_HG-U133A	MAP1B TRPC1 SCYL2 PITX1 ETAA1 NCOA1	2.67e-04	190	106	6	6769_DN
Drug	Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	TRPC1 BAG3 TRAK1 PDE4DIP ETAA1 NAV3	2.74e-04	191	106	6	7376_DN
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A	MAP3K1 TRAK1 SCYL2 CEP350 ETAA1 NFAT5	2.90e-04	193	106	6	4690_DN
Drug	5114445; Down 200; 10uM; MCF7; HT_HG-U133A_EA	TRAK1 TRIM33 UBAP2L ROBO1 NFAT5 RUBCN	2.90e-04	193	106	6	901_DN
Drug	Eburnamonine (-) [4880-88-0]; Down 200; 13.6uM; MCF7; HT_HG-U133A	TRPC1 ARHGAP26 MAP3K1 TRAK1 PDE4DIP ZNF292	2.90e-04	193	106	6	6802_DN
Drug	ICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A	NCOA2 DOCK4 ARHGAP26 MAP3K1 PHC3 NFAT5	2.98e-04	194	106	6	6165_DN
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HG-U133A	HIVEP1 SUPT20H GATA6 RB1CC1 MACF1 NFAT5	2.98e-04	194	106	6	1947_DN
Drug	Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	LARP6 MAP1B TRIM33 PHC3 MICAL3 CEP170B	3.06e-04	195	106	6	3525_DN
Drug	Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; HL60; HT_HG-U133A	NCOA2 DOCK4 TFEB RB1CC1 PITX2 NCOA1	3.06e-04	195	106	6	2478_DN
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A	RB1CC1 SCYL2 CEP350 TRIM33 PITX1 PDE4DIP	3.06e-04	195	106	6	6643_DN
Drug	Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A	SECISBP2L MAP1B IRF1 ZCCHC14 ETAA1 NCOA1	3.06e-04	195	106	6	6828_DN
Drug	Piracetam [7491-74-9]; Down 200; 28.2uM; MCF7; HT_HG-U133A	SUPT20H ZCCHC14 PITX1 PDE4DIP PITX2 MACF1	3.15e-04	196	106	6	5462_DN
Drug	Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A	RFX7 SCYL2 ABLIM1 SEC24B PDE4DIP NCOA1	3.15e-04	196	106	6	4813_DN
Drug	Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; PC3; HT_HG-U133A	NCOA2 RAP1GAP SUPT20H RFX7 SCYL2 NFAT5	3.15e-04	196	106	6	5812_DN
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	NCOA2 ESR2 IRF1 MAP3K1 ZCCHC14 PITX1	3.15e-04	196	106	6	5438_DN
Drug	Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A	HAUS5 PHC3 UBAP2L PITX1 PDE4DIP ETAA1	3.15e-04	196	106	6	6775_DN
Drug	butamben	NCOA2 NCOA1	3.18e-04	6	106	2	ctd:C004605
Drug	2,5-DCHQ	NCOA2 ESR2	3.18e-04	6	106	2	CID000000065
Drug	androstan-3-ol	NCOA6 NCOA1	3.18e-04	6	106	2	ctd:C000658
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A	TFEB ZCCHC14 PHC3 PITX1 PDE4DIP CEP170B	3.24e-04	197	106	6	3862_DN
Drug	Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A	DOCK4 POU2F2 TRAK1 ZCCHC14 PDE4DIP ETAA1	3.24e-04	197	106	6	3299_UP
Drug	Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A	NCOA2 HAUS5 CEP350 ETAA1 MACF1 ZNF292	3.24e-04	197	106	6	5340_DN
Drug	STOCK1N-35696; Up 200; 15uM; PC3; HT_HG-U133A	SECISBP2L SUPT20H RB1CC1 MAP7 UBAP2L NAV3	3.24e-04	197	106	6	6564_UP
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; PC3; HT_HG-U133A	ESR2 POU2F2 CRTC1 MAP7 NEO1 ZFHX2	3.24e-04	197	106	6	3990_UP
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; PC3; HT_HG-U133A	IRF1 MAP7 WAC ZCCHC14 ABLIM1 UBAP2L	3.24e-04	197	106	6	2052_DN
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A	NCOA2 TRPC1 CRTC1 PITX2 ZFHX2 MACF1	3.24e-04	197	106	6	7344_UP
Drug	Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A	HAUS5 MEF2A TRIM33 PITX1 PDE4DIP NFAT5	3.33e-04	198	106	6	1694_DN
Drug	Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; PC3; HT_HG-U133A	TRPC1 PHC3 NEO1 PITX2 ETAA1 MAPK10	3.33e-04	198	106	6	4241_UP
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A	HAUS5 MAP3K1 CEP350 ZCCHC14 PDE4DIP NFAT5	3.33e-04	198	106	6	5219_DN
Drug	Calciferol [50-14-6]; Down 200; 10uM; MCF7; HT_HG-U133A	SECISBP2L LARP6 MAP1B IRF1 PHC3 NFAT5	3.33e-04	198	106	6	3304_DN
Drug	Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	MAP1B CRTC1 PHC3 CD226 PITX1 MAPK10	3.33e-04	198	106	6	4964_UP
Drug	genistein; Down 200; 10uM; MCF7; HG-U133A	TRAK1 PHC3 ABLIM1 ZFHX2 NCOA1 MAPK10	3.33e-04	198	106	6	638_DN
Drug	Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A	NCOA2 TRPC1 ESR2 CRTC1 PITX1 NFAT5	3.33e-04	198	106	6	3879_UP
Drug	Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A	DOCK4 MAP7 MAP3K1 PITX2 ETAA1 MICAL3	3.33e-04	198	106	6	2724_DN
Drug	Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A	TFEB TRPC1 HAUS5 PITX2 ZFHX2 MAPK10	3.42e-04	199	106	6	2273_DN
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A	NCOA2 PHC3 PITX1 NAV2 ZFHX2 ROBO1	3.42e-04	199	106	6	2319_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	NCOA2 TFEB ARHGAP26 HAUS5 GATA6 MAP3K1	3.42e-04	199	106	6	2683_DN
Drug	Benzamil hydrochloride [2898-76-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	TFEB IRF1 CRTC1 TRAK1 PHC3 ETAA1	3.42e-04	199	106	6	6056_DN
Drug	Delsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	SECISBP2L NCOA2 SUPT20H PDE4DIP ROBO1 ZNF292	3.42e-04	199	106	6	7212_DN
Drug	Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A	TRPC1 IRF1 PDE4DIP PBX1 MAPK10 CEP170B	3.42e-04	199	106	6	3485_DN
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A	NCOA2 HAUS5 CRTC1 MAP7 TRAK1 PDE4DIP	3.42e-04	199	106	6	7287_UP
Drug	Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A	TRPC1 HAUS5 IRF1 CRTC1 ISL1 NAV3	3.42e-04	199	106	6	4555_DN
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A	TRPC1 ESR2 CRTC1 ZCCHC14 PITX1 ZFHX2	3.51e-04	200	106	6	5603_DN
Drug	Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HG-U133A	SUPT20H RB1CC1 UBAP2L NAV3 MGA CEP170B	3.51e-04	200	106	6	1953_DN
Drug	Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A	SUPT20H TRPC1 POU2F2 CRTC1 MAP3K1 PBX1	3.51e-04	200	106	6	3760_UP
Drug	Naproxen [22204-53-1]; Up 200; 17.4uM; HL60; HT_HG-U133A	RAP1GAP MAP7 MAP3K1 TRIM33 NCOA1 RUBCN	3.51e-04	200	106	6	1869_UP
Disease	neuroimaging measurement	SECISBP2L MAP1B PODXL GLIS3 VTA1 FRYL GATAD2B MAP3K1 PLEKHG1 ABLIM1 ZNF469 NEO1 NAV3 NAV2 ROBO1 MACF1	9.19e-07	1069	103	16	EFO_0004346
Disease	FEV/FEC ratio	ARHGAP26 BAG3 GLIS3 GATA6 IRF1 CRTC1 VTA1 R3HDM2 MAP3K1 TRIM33 NAV2 MICAL3 MAML2 MAPK10 MGA	2.35e-05	1228	103	15	EFO_0004713
Disease	severe acute respiratory syndrome, COVID-19	NCOA2 USP9X MYRIP CRTC1 VTA1 ABLIM1 PDE4DIP MAML2 PBX1	2.77e-05	447	103	9	EFO_0000694, MONDO_0100096
Disease	Prostatic Neoplasms	NCOA2 PODXL ESR2 MAP3K1 WAC NCOA1 ROBO1 MGA GOLGA4 ZNF292	6.05e-05	616	103	10	C0033578
Disease	Malignant neoplasm of prostate	NCOA2 PODXL ESR2 MAP3K1 WAC NCOA1 ROBO1 MGA GOLGA4 ZNF292	6.05e-05	616	103	10	C0376358
Disease	neuroimaging measurement, brain volume measurement	GLIS3 POU2F2 GATAD2B MAP3K1 NAV3 ROBO1 NFAT5	6.69e-05	286	103	7	EFO_0004346, EFO_0006930
Disease	alcohol consumption measurement, waist-hip ratio	CRTC1 MAML2	7.21e-05	4	103	2	EFO_0004343, EFO_0007878
Disease	C-reactive protein measurement	SOX6 DOCK4 TFEB NCOA6 RAP1GAP IRF1 R3HDM2 GATAD2B MAP3K1 ZNF469 NEO1 MACF1 MICAL3 NFAT5	7.78e-05	1206	103	14	EFO_0004458
Disease	retinal vasculature measurement	SOX6 XRN2 VTA1 MUC12 RB1CC1 PLEKHG1 MUC17 NAV3 PALLD	8.48e-05	517	103	9	EFO_0010554
Disease	electrocardiography	NCOA2 HIVEP1 BAG3 GATA6 TRAK1 PITX2 NAV2 MYOCD PALLD	1.02e-04	530	103	9	EFO_0004327
Disease	diastolic blood pressure, unipolar depression	SOX6 TRAK1 PLEKHG1	1.57e-04	30	103	3	EFO_0003761, EFO_0006336
Disease	thalamus volume	RFX7 NAV2 MACF1 NFAT5	2.28e-04	85	103	4	EFO_0006935
Disease	prostate carcinoma	SALL3 BCLAF1 ESR2 POU2F2 RFX7 GATAD2B MAP3K1 CEP350 PHC3 ABLIM1 MYOCD	2.85e-04	891	103	11	EFO_0001663
Disease	atrial fibrillation	ESR2 ARHGAP26 PITX1 PITX2 NAV2 MYOCD ZNF292	3.31e-04	371	103	7	EFO_0000275
Disease	peak expiratory flow	PODXL GLIS3 IRF1 VTA1 ZCCHC14 NCOA1 MLLT6 MICAL3	3.65e-04	498	103	8	EFO_0009718
Disease	Malignant neoplasm of breast	NCOA2 NCOA6 RAP1GAP ESR2 KBTBD8 RB1CC1 MAP3K1 ZCCHC14 ZNF532 NCOA1 ROBO1 MACF1	3.70e-04	1074	103	12	C0006142
Disease	response to antineoplastic agent	SOX6 GLIS3 PDE4DIP NFAT5	4.09e-04	99	103	4	GO_0097327
Disease	influenza A severity measurement	CRTC1 MAML2	4.28e-04	9	103	2	EFO_0007743
Disease	intermittent Staphylococcus aureus carrier status	ZNF532 ROBO1	4.28e-04	9	103	2	EFO_0007758
Disease	pancreatic cancer (is_marker_for)	RAP1GAP BAG3 MUC16 PALLD	4.41e-04	101	103	4	DOID:1793 (is_marker_for)
Disease	dilated cardiomyopathy (is_implicated_in)	CDK8 ISL1 MEF2A	4.61e-04	43	103	3	DOID:12930 (is_implicated_in)
Disease	testosterone measurement	SOX6 DOCK4 TFEB NCOA6 ESR2 ARHGAP26 GLIS3 R3HDM2 ZC3H7A NCOA1 MACF1 MYOCD MAPK10	4.98e-04	1275	103	13	EFO_0004908
Disease	cortical thickness	NCOA2 GLIS3 GATAD2B MAP3K1 PLEKHG1 ZNF469 NEO1 NAV3 NAV2 ROBO1 MACF1 MICAL3	5.08e-04	1113	103	12	EFO_0004840
Disease	thiamine measurement	CRTC1 MAML2	5.33e-04	10	103	2	EFO_0010540
Disease	coffee consumption measurement, insomnia	SUPT20H PODXL	5.33e-04	10	103	2	EFO_0004698, EFO_0006781
Disease	nucleus accumbens volume change measurement	MUC16 MAPK10	6.50e-04	11	103	2	EFO_0021493
Disease	brain measurement, neuroimaging measurement	GLIS3 GATAD2B MAP3K1 NEO1 NAV3 NAV2 ROBO1 MACF1	6.99e-04	550	103	8	EFO_0004346, EFO_0004464
Disease	Colorectal Carcinoma	SALL3 MAP1B ESR2 WAC LIG1 CD226 NPAP1 ETAA1 ZNF292	7.98e-04	702	103	9	C0009402
Disease	hematocrit	SOX6 HIVEP1 ESR2 ARHGAP26 GLIS3 CRTC1 R3HDM2 PLEKHG1 MIDN MAML2 NFAT5	8.16e-04	1011	103	11	EFO_0004348
Disease	cortical surface area measurement	NCOA2 PODXL GLIS3 FRYL GATAD2B MAP3K1 PLEKHG1 ZNF469 NEO1 NAV3 NAV2 ROBO1 MACF1	8.18e-04	1345	103	13	EFO_0010736
Disease	plasminogen activator inhibitor 1 measurement	MUC12 RFX7 MUC17	9.00e-04	54	103	3	EFO_0004792
Disease	Acute Cerebrovascular Accidents	IRF1 ZCCHC14 PITX2	9.00e-04	54	103	3	C0751956
Disease	alcohol and nicotine codependence	HIVEP1 PLEKHG1	9.18e-04	13	103	2	EFO_0004776
Disease	coronary artery disease	CDK8 SOX6 NCOA6 MAP1B ARHGAP26 IRF1 R3HDM2 MAP3K1 PLEKHG1 FNDC1 NFAT5 PALLD	9.39e-04	1194	103	12	EFO_0001645
Disease	red blood cell density measurement	SOX6 XRN2 HIVEP1 PODXL ESR2 CRTC1 R3HDM2 RFX7 TRIM33 MAML2	1.02e-03	880	103	10	EFO_0007978
Disease	ventricular septal defect (is_implicated_in)	GATA6 ISL1	1.07e-03	14	103	2	DOID:1657 (is_implicated_in)
Disease	Testicular Germ Cell Tumor	DAZL PITX1	1.07e-03	14	103	2	C1336708
Disease	caffeine measurement	CRTC1 MAML2	1.23e-03	15	103	2	EFO_0021177
Disease	Burkitt Leukemia	SALL3 PBX1	1.23e-03	15	103	2	C4721444
Disease	African Burkitt's lymphoma	SALL3 PBX1	1.23e-03	15	103	2	C0343640
Disease	Cerebrovascular accident	IRF1 ZCCHC14 PITX2	1.35e-03	62	103	3	C0038454
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	RFX7 ZNF292	1.59e-03	17	103	2	DOID:0060307 (is_implicated_in)
Disease	keratoconus	CRTC1 ZNF469 MAML2	1.61e-03	66	103	3	MONDO_0015486
Disease	PR interval	DOCK4 TFEB TRAK1 ZNF469 NAV2 MACF1 MYOCD	1.78e-03	495	103	7	EFO_0004462
Disease	Feeding difficulties	CDK8 ZNF292	1.78e-03	18	103	2	C0232466
Disease	breast cancer (is_implicated_in)	NCOA6 ESR2 RB1CC1 MAP3K1	1.92e-03	150	103	4	DOID:1612 (is_implicated_in)
Disease	acute lymphoblastic leukemia, response to antineoplastic agent	CRTC1 MAML2	1.99e-03	19	103	2	EFO_0000220, GO_0097327
Disease	cumulative dose response to bevacizumab	CRTC1 MAML2	1.99e-03	19	103	2	EFO_0005944
Disease	leucine measurement	VTA1 RB1CC1 MAPK10	2.15e-03	73	103	3	EFO_0009770
Disease	Paroxysmal atrial fibrillation	ESR2 PITX2 NAV2 MYOCD	2.21e-03	156	103	4	C0235480
Disease	familial atrial fibrillation	ESR2 PITX2 NAV2 MYOCD	2.21e-03	156	103	4	C3468561
Disease	Persistent atrial fibrillation	ESR2 PITX2 NAV2 MYOCD	2.21e-03	156	103	4	C2585653
Disease	skin hydration measurement	PLEKHG1 ABLIM1	2.43e-03	21	103	2	EFO_0009586
Disease	osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty	CRTC1 MAML2	2.43e-03	21	103	2	EFO_0004616, EFO_0010726, EFO_1000786
Disease	HIV-1 infection, Susceptibility to viral and mycobacterial infections	PODXL NAV2	2.43e-03	21	103	2	EFO_0000180, Orphanet_391311
Disease	Atrial Fibrillation	ESR2 PITX2 NAV2 MYOCD	2.43e-03	160	103	4	C0004238
Disease	Endometrioma	NCOA6 ESR2 CD226 NCOA1	2.48e-03	161	103	4	C0269102
Disease	Endometriosis	NCOA6 ESR2 CD226 NCOA1	2.48e-03	161	103	4	C0014175
Disease	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	GATA6 PITX2	2.66e-03	22	103	2	C1843687
Disease	hypothyroidism (biomarker_via_orthology)	MAP1B PITX2 NCOA1	2.79e-03	80	103	3	DOID:1459 (biomarker_via_orthology)
Disease	dilated cardiomyopathy (implicated_via_orthology)	NCOA6 BAG3 MYOCD	2.79e-03	80	103	3	DOID:12930 (implicated_via_orthology)
Disease	beverage consumption measurement	DOCK4 HIVEP1 NCOA1	3.10e-03	83	103	3	EFO_0010088
Disease	congenital heart disease (is_implicated_in)	GATA6 ISL1	3.17e-03	24	103	2	DOID:1682 (is_implicated_in)
Disease	lung adenocarcinoma	SECISBP2L RFX7 ETAA1 NCOA1	3.28e-03	174	103	4	EFO_0000571
Disease	Neonatal diabetes mellitus	GLIS3 GATA6	3.44e-03	25	103	2	C0158981

Protein segments in the cluster

Peptide	Gene	Start	Entry
MASPTLSPDSSSQEA	EVI5L	1	Q96CN4
TSPQESLSSMSPISS	MLLT6	661	P55198
PMLSTADKSSDSSSP	CXorf66	111	Q5JRM2
QPMSSSPKETTFSSN	ABLIM1	211	O14639
SSEPAHSASLSNMPS	CEP170B	1356	Q9Y4F5
YSPDSSPQANTQMSS	R3HDM2	746	Q9Y2K5
SPQANTQMSSSPVTS	R3HDM2	751	Q9Y2K5
QMTAPLPNSASVSSS	RBM11	201	P57052
DNAPELTMSTLSSPT	PCDHB5	341	Q9Y5E4
NFQVSPMPSTSEATT	IRF1	211	P10914
TSPQSASSPRMESTA	RB1CC1	646	Q8TDY2
QSTPPMDNTTTGSSS	MUC16	1626	Q8WXI7
SSSRGPSPDQSTMSQ	MUC16	9041	Q8WXI7
PSTPNSAGSSSSFNM	PBX1	326	P40424
TQQTSSQMPASSTAP	PODXL	276	O00592
SQMPASSTAPSSQET	PODXL	281	O00592
GSQSFNTSDSAMLTP	MICAL3	1441	Q7RTP6
SPSKSSPMTAAETSQ	FAM156A	11	Q8NDB6
MESSPIPQSSGNSST	GPR61	1	Q9BZJ8
NASASTISPPSSMEE	MAP1B	1201	P46821
PAMVSAPSSTVNASA	MAP7	451	Q14244
MDIKNSPSSLNSPSS	ESR2	1	Q92731
SLPPSSSVNDISSMS	MAPK10	426	P53779
DANTSNTVPNTTMPS	MGAM2	2071	Q2M2H8
TPPSSTSSSAFSVMN	MGA	1851	Q8IWI9
APAQASSNSSTPTRM	GOLGA4	21	Q13439
MSTLPTQIAPNSSTS	OR51S1	1	Q8NGJ8
TQIAPNSSTSMAPTF	OR51S1	6	Q8NGJ8
GNQSPLVSPSAMSSS	NAV3	1456	Q8IVL0
TSSSNTMVAPTDGNP	FRYL	1481	O94915
YQPSPMTDSGLSSSS	FRYL	1701	O94915
MSVDSSLPSPNQLSS	POU2F2	271	P09086
SQSNHSCTSMPSSPA	MACF1	3366	O94854
ANSSSDPESNPTSPM	LARP6	336	Q9BRS8
LPSPSAMTDAANSQA	GATAD2B	336	Q8WXI9
QAPDQSDSSQTLPSM	HAUS5	276	O94927
SSTLTDSSMLSPPQT	MEF2A	171	Q02078
HSQTSTTSSEQMQPP	NFAT5	1101	O94916
SMSQTSINLSTSPTP	PHC3	121	Q8NDX5
LSPMQTQFSPSSVDS	MYOCD	861	Q8IZQ8
MDSLSSSFSSPNDPD	ETAA1	86	Q9NY74
MAASADLSKSSPTPN	KBTBD8	1	Q8NFY9
PSALLSASASQSPME	PALLD	211	Q8WX93
FSMANSALSTSSPIP	MAML2	391	Q8IZL2
QNTLPSSQSTTMVSP	NCOA6	1781	Q14686
GNSNNSIPMTPTSTS	GATA6	506	Q92908
SIPMTPTSTSSNSDD	GATA6	511	Q92908
EVFNMQPSPSTSSLS	DOCK4	1666	Q8N1I0
HQSTMTPTQPESFSS	CRTC1	156	Q6UUV9
QSSPAAPTMLDSSAA	C21orf58	76	P58505
ASAIQQDSTSSMQPP	C19orf44	441	Q9H6X5
PATNSNAPSRSTMSS	FNDC1	751	Q4ZHG4
PSQSSSCSDAPMLST	BCLAF1	236	Q9NYF8
PGTSMSSNSVSNSLP	GLIS3	101	Q8NEA6
VQERPPSASSSSDMS	CEP350	701	Q5VT06
NSAPILNMSSSSGSS	KLF17	31	Q5JT82
MSTANPETPNSTISR	DAZL	1	Q92904
RSPISTSQPTNQSMD	CD226	301	Q15762
PTMAASSVTLPSNCS	EBF3	526	Q9H4W6
QPEATAAATSNPSSM	BAG3	551	O95817
AAATSNPSSMTDTPG	BAG3	556	O95817
PSTSQPQSSMGYSAT	CDK8	436	P49336
NNASLSDTSPMDSSP	LIG1	101	P18858
DSPLTPNEMSSSTLT	RUBCN	286	Q92622
DSSSTTSSASPMPNS	SEC24B	391	O95487
SQSTPSLISSAAPTM	SALL3	1046	Q9BXA9
SSDEGSPSASTPMIN	LRRC8D	241	Q7L1W4
SSPTTSEGTSMPNSN	MUC17	1376	Q685J3
SQLMFPALSTPSSST	MAP3K1	976	Q13233
PEQMDCSPTASSSAS	MIDN	231	Q504T8
SPLSSQSMFSAPSSI	PITX1	206	P78337
TQISSNMPSSPDSSS	USP9X	966	Q93008
NMPSSPDSSSDSSTG	USP9X	971	Q93008
NPTSPTTATMANANR	TRIM33	641	Q9UPN9
LSSSAGNSAPNSPMA	TFEB	131	P19484
ARSSTLPPSNSNMVS	NCOA1	401	Q15788
TPSTDTMPASSSQTC	NEO1	1306	Q92859
ASPTTVTQMSLSNPT	NAV2	1571	Q8IVL1
NSSSSLQPNMNSSDP	ARHGAP26	636	Q9UNA1
NSSTQSSPEMPTTKN	RAP1GAP	536	P47736
NFAQPPTTMTNSSSA	SCYL2	906	Q6P3W7
SMPSDTSLSPASQNS	SECISBP2L	626	Q93073
QPSNQSPMSLTSDAS	WAC	431	Q9BTA9
FSPPNSISSMSMSSS	PITX2	211	Q99697
SEVASMSSQLPDTPN	ISL1	326	P61371
TETMTNSSITQPAPS	NPAP1	386	Q9NZP6
PQMTSDCSSTSASPE	SOX6	756	P35712
QMEPSPLASSLSDTN	NCOA2	651	Q15596
PGSNQSSAMNSLLSS	TRAK1	426	Q9UPV9
SSPSSSSPNEVMALK	TRPC1	21	P48995
PADQMIVSPSSNTST	ZNF532	686	Q9HCE3
TPSSSMSSPNGNSSV	USP42	476	Q9H9J4
TSSNMPLPASSSTQR	TMPRSS11F	191	Q6ZWK6
TPSTMENDSSNLDPS	UBAP2L	291	Q14157
TSAPQMSPGSSDNQS	UBAP2L	461	Q14157
PPAASSTSENMRSSE	ZFHX2	41	Q9C0A1
PMPDQTNTSTAGTTD	ZFHX2	2281	Q9C0A1
SPSNAAAMAPSTAVS	PHF21B	156	Q96EK2
TQPSSSSTYDPSNMP	VTA1	191	Q9NP79
SALDSTSSSMQPSPV	ZFAND6	76	Q6FIF0
TSSSMQPSPVSNQSL	ZFAND6	81	Q6FIF0
SMLSPAALSPASSSQ	SUPT20H	516	Q8NEM7
MQNNSSPSISPNTSF	XRN2	466	Q9H0D6
SMSLFPSPADSGTNS	ZNF292	1271	O60281
FPSANPQNMIDSSTS	RFX7	1196	Q2KHR2
NNPRDPSSSSSMSSR	ROBO1	1596	Q9Y6N7
FNMPSSPDSSSDSST	USP9Y	971	O00507
MSSSPANPSSEESQL	ZNF469	611	Q96JG9
LQSSNSPMTAAACSP	UBALD2	91	Q8IYN6
QTASVSPSMPFSASL	ZC3H7A	311	Q8IWR0
TASPSSHPSTSFANM	ZCCHC14	706	Q8WYQ9
SPAQRNSQPSSSTMI	PLEKHG1	506	Q9ULL1
TMDSPSLSSSPNINS	TOGARAM1	1006	Q9Y4F4
QMDSASPLSISPANS	HIVEP1	351	P15822
SSSRSPDQTLSPASM	MUC12	4886	Q9UKN1
PDQTLSPASMTSSSI	MUC12	4891	Q9UKN1
MNSPALVFPSSASST	PDE4DIP	2121	Q5VU43
SSALSPNPEAMCSDS	MYRIP	441	Q8NFW9
QQMTEFSNPSPSTSI	NDC1	491	Q9BTX1